| WATER'S EDGE DERMATOLOGY | 68.3 | 2 | 2 |
| Cosmopolitan | 60.0 | 4 | 0 |
| Mayo Clinic | 60.0 | 4 | 0 |
| Cleveland Clinic | 60.0 | 4 | 0 |
| The Journal of clinical and aesthetic dermatology | 60.0 | 4 | 0 |
| United States National Institutes of Health | 51.7 | 3 | 0 |
| Rutgers University | 51.7 | 3 | 0 |
| JAMA Facial Plastic Surgery | 51.7 | 3 | 0 |
| JAMA Surgery | 51.7 | 3 | 0 |
| Challenges and strategies in building a foundational digital health data integration ecosystem: a systematic review and thematic synthesis | 51.7 | 3 | 0 |
| Clinical trial NCT07597382 | 51.7 | 3 | 0 |
| Clinical trial NCT07585825 | 51.7 | 3 | 0 |
| Clinical trial NCT07571616 | 51.7 | 3 | 0 |
| Clinical trial NCT07571629 | 51.7 | 3 | 0 |
| Clinical trial NCT07611032 | 51.7 | 3 | 0 |
| International Society for Dermatologic Surgery | 43.1 | 1 | 1 |
| Cetaphil | 43.1 | 1 | 1 |
| Skin Cancer Foundation | 43.1 | 1 | 1 |
| CeraVe | 43.1 | 1 | 1 |
| Baumann Cosmetic Dermatology | 43.1 | 1 | 1 |
| American Society for Dermatologic Surgery | 43.1 | 1 | 1 |
| Society For Pediatric Dermatology | 43.1 | 1 | 1 |
| Schweiger Dermatology Group (United States) | 43.1 | 1 | 1 |
| University of Pennsylvania | 41.0 | 2 | 0 |
| Massachusetts General Hospital | 41.0 | 2 | 0 |
| Nucleic Acids Research | 41.0 | 2 | 0 |
| Q229883 | 41.0 | 2 | 0 |
| The New England Journal of Medicine | 41.0 | 2 | 0 |
| National Cancer Institute | 41.0 | 2 | 0 |
| The Journal of the American Medical Association | 41.0 | 2 | 0 |
| American Family Physician | 41.0 | 2 | 0 |
| American Journal of Translational Research | 41.0 | 2 | 0 |
| Biomedical Optics Express | 41.0 | 2 | 0 |
| ClinicalTrials.gov | 41.0 | 2 | 0 |
| dbSNP | 41.0 | 2 | 0 |
| drugs.com | 41.0 | 2 | 0 |
| Western Journal of Medicine | 41.0 | 2 | 0 |
| Trends in Amplification | 41.0 | 2 | 0 |
| Ulster Medical Journal | 41.0 | 2 | 0 |
| UpToDate | 41.0 | 2 | 0 |
| The AAPS Journal | 41.0 | 2 | 0 |
| Rice | 41.0 | 2 | 0 |
| AAPS PharmSciTech | 41.0 | 2 | 0 |
| International Journal of Mental Health Systems | 41.0 | 2 | 0 |
| Journal of Urban Health | 41.0 | 2 | 0 |
| Neural Development | 41.0 | 2 | 0 |
| Journal of the Society of Laparoendoscopic Surgeons | 41.0 | 2 | 0 |
| National Health Service | 41.0 | 2 | 0 |
| National Organization for Rare Disorders | 41.0 | 2 | 0 |
| HealthGrades | 41.0 | 2 | 0 |
| Q20641742 | 41.0 | 2 | 0 |
| Luton and Dunstable University Hospital NHS Foundation Trust | 41.0 | 2 | 0 |
| Alcohol research : current reviews | 41.0 | 2 | 0 |
| American Society of Clinical Oncology educational book / ASCO | 41.0 | 2 | 0 |
| Dermato-endocrinology | 41.0 | 2 | 0 |
| British Heart Journal | 41.0 | 2 | 0 |
| The western journal of emergency medicine | 41.0 | 2 | 0 |
| Psychiatry | 41.0 | 2 | 0 |
| Mycobiology | 41.0 | 2 | 0 |
| JAMA cardiology | 41.0 | 2 | 0 |
| Boscombe Community Hospital | 41.0 | 2 | 0 |
| Advanced Dermatology & Cosmetic Surgery | 41.0 | 2 | 0 |
| CaosDB - Research Data Management for Complex, Changing, and Automated Research Workflows | 41.0 | 2 | 0 |
| Johns Hopkins Medicine | 41.0 | 2 | 0 |
| bidirectional encoder representations from transformers | 41.0 | 2 | 0 |
| JAMA Network Open | 41.0 | 2 | 0 |
| Christopher R. Conley | 41.0 | 2 | 0 |
| Q96602914 | 41.0 | 2 | 0 |
| Boston Medical and Surgical Journal | 41.0 | 2 | 0 |
| The New England Journal of Medicine and Surgery and the Collateral Branches of Science | 41.0 | 2 | 0 |
| The New-England Medical Review and Journal | 41.0 | 2 | 0 |
| University of Pennsylvania Division of Endocrinology, Diabetes and Metabolism | 41.0 | 2 | 0 |
| Merck Manual Professional Edition | 41.0 | 2 | 0 |
| Center for Medicaid and CHIP Services | 41.0 | 2 | 0 |
| SPARQL Generation: an analysis on fine-tuning OpenLLaMA for Question Answering over a Life Science Knowledge Graph | 41.0 | 2 | 0 |
| WebMD Magazine | 41.0 | 2 | 0 |
| INSIDEA | 41.0 | 2 | 0 |
| Treatment of Basal Cell Carcinoma in the Elderly: What Nondermatologists Need to Know | 40.0 | 0 | 4 |
| Mohs Surgery versus Standard Local Excision for Basal Cell Carcinoma, Squamous Cell Carcinoma, and Melanoma Skin Cancer | 40.0 | 0 | 4 |
| Erratum: Mohs Surgery versus Standard Local Excision for Basal Cell Carcinoma, Squamous Cell Carcinoma, and Melanoma Skin Cancer | 40.0 | 0 | 4 |
| Pediatric Dermatology | 34.5 | 0 | 3 |
| American College of Mohs Surgery | 34.5 | 0 | 3 |
| Q28274622 | 34.5 | 0 | 3 |
| Guidelines for the management of squamous cell carcinoma in organ transplant recipients | 34.5 | 0 | 3 |
| Therapeutic ionizing radiation and the incidence of basal cell carcinoma and squamous cell carcinoma. The New Hampshire Skin Cancer Study Group | 34.5 | 0 | 3 |
| Skin Cancer Epidemiology, Detection, and Management | 34.5 | 0 | 3 |
| Consensus for nonmelanoma skin cancer treatment: basal cell carcinoma, including a cost analysis of treatment methods | 34.5 | 0 | 3 |
| Association of CRR9 locus with elevated risk of squamous cell carcinoma and basal cell carcinoma | 34.5 | 0 | 3 |
| Trends in Non-Melanoma Skin Cancer (Basal Cell Carcinoma and Squamous Cell Carcinoma) in Canada: A Descriptive Analysis of Available Data | 34.5 | 0 | 3 |
| AAD/ACMS/ASDSA/ASMS 2012 appropriate use criteria for Mohs micrographic surgery: a report of the American Academy of Dermatology, American College of Mohs Surgery, American Society for Dermatologic Surgery Association, and the American Society for M | 34.5 | 0 | 3 |
| Topical Treatment of Basal Cell Carcinoma with the Immune Response Modifier Imiquimod | 34.5 | 0 | 3 |
| Skin Cancer (Basal Cell Carcinoma, Squamous Cell Carcinoma, and Malignant Melanoma): New Cases, Treatment Practice, and Health Care Costs in New Brunswick, Canada, 2002–2010 | 34.5 | 0 | 3 |
| Defining recurrence of nonmelanoma skin cancer after Mohs micrographic surgery: Report of the American College of Mohs Surgery Registry and Outcomes Committee | 34.5 | 0 | 3 |
| Risk of subsequent basal cell carcinoma and squamous cell carcinoma of the skin among patients with prior skin cancer. Skin Cancer Prevention Study Group | 34.5 | 0 | 3 |
| The big three of skin cancer: basal cell carcinoma, squamous cell carcinoma, and malignant melanoma | 34.5 | 0 | 3 |
| Geographic variation and risk of skin cancer in US women. Differences between melanoma, squamous cell carcinoma, and basal cell carcinoma | 34.5 | 0 | 3 |
| Acitretin in Preventing Skin Cancer in Patients at High Risk for Skin Cancer | 34.5 | 0 | 3 |
| Correlation Between Skin Carotenoid Levels and Previous History of Skin Cancer | 34.5 | 0 | 3 |
| Photodynamic Therapy in Treating Patients With Skin Cancer (1993-11-30) | 34.5 | 0 | 3 |
| Non-melanoma Skin Cancer - a Clinicopathological Study of Patients with Basal Cell Carcinoma and Squamous Cell Carcinoma | 34.5 | 0 | 3 |
| Appropriate use criteria for basal cell carcinoma Mohs surgery at a single center in the face of high-burden skin cancer: a retrospective cohort study | 34.5 | 0 | 3 |
| Recurrence of periocular basal cell carcinoma and squamous cell carcinoma after Mohs micrographic surgery: a retrospective cohort study | 34.5 | 0 | 3 |
| Differences of Mohs micrographic surgery in basal cell carcinoma versus squamous cell carcinoma | 34.5 | 0 | 3 |
| Childhood Basal Cell Carcinoma and Squamous Cell Carcinoma of the Skin Treatment (PDQ®): Health Professional Version | 34.5 | 0 | 3 |
| Childhood Basal Cell Carcinoma and Squamous Cell Carcinoma of the Skin Treatment (PDQ®): Patient Version | 34.5 | 0 | 3 |
| skin cancer | 27.3 | 0 | 2 |
| basal-cell carcinoma of the skin | 27.3 | 0 | 2 |
| skin care | 27.3 | 0 | 2 |
| La Roche-Posay | 27.3 | 0 | 2 |
| Mohs surgery | 27.3 | 0 | 2 |
| cutaneous squamous-cell carcinoma | 27.3 | 0 | 2 |
| Dermatologic Surgery | 27.3 | 0 | 2 |
| No7 product line | 27.3 | 0 | 2 |
| Mohs micrographic surgery versus surgical excision for periocular basal cell carcinoma | 27.3 | 0 | 2 |
| Mohs micrographic surgery versus surgical excision for periocular basal cell carcinoma | 27.3 | 0 | 2 |
| Mohs micrographic surgery versus surgical excision for periocular basal cell carcinoma | 27.3 | 0 | 2 |
| Novel treatment options for nonmelanoma skin cancer: focus on electronic brachytherapy | 27.3 | 0 | 2 |
| Targeted Therapy for Orbital and Periocular Basal Cell Carcinoma and Squamous Cell Carcinoma | 27.3 | 0 | 2 |
| Point of care cutaneous imaging technology in melanoma screening and mole mapping | 27.3 | 0 | 2 |
| The Journal of dermatologic surgery and oncology | 27.3 | 0 | 2 |
| Basal cell carcinoma, squamous cell carcinoma and melanoma of the head and face | 27.3 | 0 | 2 |
| Dermoscopic differentiation of a superficial basal cell carcinoma and squamous cell carcinoma in situ | 27.3 | 0 | 2 |
| Genome-wide association study identifies novel alleles associated with risk of cutaneous basal cell carcinoma and squamous cell carcinoma | 27.3 | 0 | 2 |
| Long Island Skin Cancer and Dermatologic Surgery | 27.3 | 0 | 2 |
| Basal cell carcinoma vs basaloid squamous cell carcinoma of the skin: an immunohistochemical reappraisal. | 27.3 | 0 | 2 |
| XRCC3 C18067T Polymorphism Contributes a Decreased Risk to Both Basal Cell Carcinoma and Squamous Cell Carcinoma: Evidence from a Meta-Analysis | 27.3 | 0 | 2 |
| Optical Coherence Tomography Used as a Modality to Delineate Basal Cell Carcinoma prior to Mohs Micrographic Surgery | 27.3 | 0 | 2 |
| Nasal cavity squamous cell carcinoma presenting as a nasal sidewall nodule: treatment with Mohs surgery, partial rhinectomy, and adjuvant radiotherapy | 27.3 | 0 | 2 |
| Mohs micrographic surgery of the nail unit and squamous cell carcinoma | 27.3 | 0 | 2 |
| Basal cell carcinoma, squamous cell carcinoma and melanoma of the skin: analysis of the Singapore Cancer Registry data 1968-97. | 27.3 | 0 | 2 |
| The risk of non-melanoma skin cancer in HIV-infected patients: new data and meta-analysis | 27.3 | 0 | 2 |
| Medicare claims data reliably identify treatments for basal cell carcinoma and squamous cell carcinoma: a prospective cohort study. | 27.3 | 0 | 2 |
| Treatment of Superficial Basal Cell Carcinoma and Squamous Cell Carcinoma In Situ With a High-Energy Pulsed Carbon Dioxide Laser | 27.3 | 0 | 2 |
| Squamous cell carcinoma of the lip treated with Mohs micrographic surgery: Outcome at 5 years | 27.3 | 0 | 2 |
| Skin diseases in Chinese children at a pediatric dermatology center | 27.3 | 0 | 2 |
| Repeated occurrence of basal cell carcinoma of the skin and multifailure survival analysis: follow-up data from the Nambour Skin Cancer Prevention Trial | 27.3 | 0 | 2 |
| Actinic keratoses, basal cell carcinoma, and squamous cell carcinoma: uncommon treatments | 27.3 | 0 | 2 |
| Heat shock protein 105 is overexpressed in squamous cell carcinoma and extramammary Paget disease but not in basal cell carcinoma | 27.3 | 0 | 2 |
| Incorporating photodynamic therapy into a medical and cosmetic dermatology practice | 27.3 | 0 | 2 |
| Current recommendations in the treatment of basal cell carcinoma and squamous cell carcinoma of the skin | 27.3 | 0 | 2 |
| Formalin-fixed tissue Mohs surgery (slow Mohs) for basal cell carcinoma: 5-year follow-up data | 27.3 | 0 | 2 |
| Should variation of serum lipid levels be considered a risk factor for the development of basal cell carcinoma? | 27.3 | 0 | 2 |
| Squamous cell carcinoma, not basal cell carcinoma, is the most common cancer in humans | 27.3 | 0 | 2 |
| Issues in the delivery of dermatologic surgery for skin cancer | 27.3 | 0 | 2 |
| Comparison of ex vivo optical coherence tomography with conventional frozen-section histology for visualizing basal cell carcinoma during Mohs micrographic surgery. | 27.3 | 0 | 2 |
| Systemic glucocorticoid use and early-onset basal cell carcinoma | 27.3 | 0 | 2 |
| A simple intervention to reinforce awareness of tanning bed use and skin cancer in non‐medical skin care professionals in Southern California | 27.3 | 0 | 2 |
| Citrus consumption and risk of basal cell carcinoma and squamous cell carcinoma of the skin | 27.3 | 0 | 2 |
| Knowledge, understanding, and use of preventive strategies against nonmelanoma skin cancer in healthy and immunosuppressed individuals undergoing Mohs surgery | 27.3 | 0 | 2 |
| Using a Hydroquinone/Tretinoin-based Skin Care System Before and After Electrodesiccation and Curettage of Superficial Truncal Basal Cell Carcinoma: A Multicenter, Randomized, Investigator-blind, Controlled Study of Short-term Healing | 27.3 | 0 | 2 |
| Melanoma screening by means of complete skin exams for all patients in a dermatology practice reduces the thickness of primary melanomas at diagnosis | 27.3 | 0 | 2 |
| Sequential occurrence of basal cell carcinoma in symmetrically identical positions of both lower eyelids: A rare finding of a common skin cancer | 27.3 | 0 | 2 |
| Mohs micrographic surgery for facial skin cancer | 27.3 | 0 | 2 |
| Surgical margins in the treatment of nonmelanoma skin cancer and mohs micrographic surgery | 27.3 | 0 | 2 |
| Optical Coherence Tomography–Based Optimization of Mohs Micrographic Surgery of Basal Cell Carcinoma: A Pilot Study | 27.3 | 0 | 2 |
| A role for sunlight in skin cancer: UV-induced p53 mutations in squamous cell carcinoma | 27.3 | 0 | 2 |
| TERT promoter mutations are frequent in cutaneous basal cell carcinoma and squamous cell carcinoma | 27.3 | 0 | 2 |
| Optimization of multimodal spectral imaging for assessment of resection margins during Mohs micrographic surgery for basal cell carcinoma | 27.3 | 0 | 2 |
| Relationship of treatment delay with surgical defect size from keratinocyte carcinoma (basal cell carcinoma and squamous cell carcinoma of the skin). | 27.3 | 0 | 2 |
| Test characteristics of high-resolution ultrasound in the preoperative assessment of margins of basal cell and squamous cell carcinoma in patients undergoing Mohs micrographic surgery | 27.3 | 0 | 2 |
| Subclinical infiltration of Basal cell carcinoma in asian patients: assessment after mohs micrographic surgery | 27.3 | 0 | 2 |
| Basal cell carcinoma-treatments for the commonest skin cancer | 27.3 | 0 | 2 |
| Plantar basal cell carcinoma in a patient with xeroderma pigmentosum: importance of dermoscopy for early diagnosis of nonpigmented skin cancer | 27.3 | 0 | 2 |
| 1064 nm long‐pulsed Nd:YAG laser treatment of basal cell carcinoma | 27.3 | 0 | 2 |
| Treatment of superficial basal cell carcinoma and squamous cell carcinoma in situ on the trunk and extremities with ablative fractional laser-assisted delivery of topical fluorouracil | 27.3 | 0 | 2 |
| Fundamentals of skin cancer/melanoma screening campaigns | 27.3 | 0 | 2 |
| Topical calcitriol prior to photodynamic therapy enhances treatment efficacy in non-melanoma skin cancer mouse models | 27.3 | 0 | 2 |
| Intralesional interferon alpha-2b in the treatment of basal cell carcinoma and squamous cell carcinoma: revisited | 27.3 | 0 | 2 |
| Basal cell carcinoma: pathogenesis, epidemiology, clinical features, diagnosis, histopathology, and management | 27.3 | 0 | 2 |
| Development of the facial skin care index: a health-related outcomes index for skin cancer patients | 27.3 | 0 | 2 |
| Ambient temperature and risk of first primary basal cell carcinoma: a nationwide United States cohort study | 27.3 | 0 | 2 |
| Photodynamic therapy followed by Mohs micrographic surgery compared to Mohs micrographic surgery alone for the treatment of basal cell carcinoma: Results of a pilot single-blinded randomised controlled trial | 27.3 | 0 | 2 |
| Novel Approaches to Imaging Basal Cell Carcinoma | 27.3 | 0 | 2 |
| Incorporation of Electronic Brachytherapy for Skin Cancer into a Community Dermatology Practice | 27.3 | 0 | 2 |
| Giant epithelial malignancies (Basal cell carcinoma, squamous cell carcinoma): a series of 20 tumors from a single center | 27.3 | 0 | 2 |
| Body dysmorphic disorder: suggestions for detection and treatment in a surgical dermatology practice | 27.3 | 0 | 2 |
| Surgical margins of excision for basal cell carcinoma and squamous cell carcinoma | 27.3 | 0 | 2 |
| Breast carcinoma masquerading as basal cell carcinoma of the nipple | 27.3 | 0 | 2 |
| Ablative Fractional Laser-Assisted Topical Fluorouracil for the Treatment of Superficial Basal Cell Carcinoma and Squamous Cell Carcinoma In Situ: A Follow-Up Study | 27.3 | 0 | 2 |
| Squamous cell carcinoma and basal cell carcinoma arising in a naevus sebaceous of Jadassohn: case report and literature review | 27.3 | 0 | 2 |
| Penile Squamous Cell Carcinoma: Penis-Preserving Treatment With Mohs Micrographic Surgery | 27.3 | 0 | 2 |
| Presurgical mapping of basal cell carcinoma or squamous cell carcinoma by confocal laser endomicroscopy compared to traditional micrographic surgery: a single-centre prospective feasibility study | 27.3 | 0 | 2 |
| Reasons for new referral non-attendance at a pediatric dermatology center: a telephone survey | 27.3 | 0 | 2 |
| The importance of superficial basal cell carcinoma in a retrospective study of 139 patients who underwent Mohs micrographic surgery in a Brazilian university hospital | 27.3 | 0 | 2 |
| Effectiveness of Mohs micrographic surgery for nonmelanoma skin cancer: a systematic review protocol. | 27.3 | 0 | 2 |
| Female estrogen-related factors and incidence of basal cell carcinoma in a nationwide US cohort | 27.3 | 0 | 2 |
| Squamous cell carcinoma of the auricle and Mohs micrographic surgery | 27.3 | 0 | 2 |
| Reduction of immunosuppression for transplant-associated skin cancer: expert consensus survey | 27.3 | 0 | 2 |
| The retinoid signalling molecule, TRIM16, is repressed during squamous cell carcinoma skin carcinogenesis in vivo and reduces skin cancer cell migration in vitro | 27.3 | 0 | 2 |
| Skin care: from skin health to ulcer prevention. | 27.3 | 0 | 2 |
| Epidemiological data on infantile seborrheic dermatitis in 12 years of ambulatory care activity (1974-1985) at the Institute of Clinical Dermatology I and Pediatric Dermatology of the University of Milan | 27.3 | 0 | 2 |
| Basal cell carcinoma with mixed histology: a possible pathogenesis for recurrent skin cancer | 27.3 | 0 | 2 |
| Protein kinase Cepsilon and development of squamous cell carcinoma, the nonmelanoma human skin cancer | 27.3 | 0 | 2 |
| Basal cell carcinoma of the nail unit treated with Mohs micrographic surgery: superficial multicentric BCC with jagged borders--a histopathological hallmark for nail unit BCC. | 27.3 | 0 | 2 |
| Specialist dermatology clinics for organ transplant recipients significantly improve compliance with photoprotection and levels of skin cancer awareness. | 27.3 | 0 | 2 |
| Evaluation of prospectively collected presenting signs/symptoms of biopsy-proven melanoma, basal cell carcinoma, squamous cell carcinoma, and seborrheic keratosis in an elderly male population | 27.3 | 0 | 2 |
| The use of antidesmoglein stains in Mohs micrographic surgery. A potential aid for the differentiation of basal cell carcinoma from horizontal sections of the hair follicle and folliculocentric basaloid proliferation | 27.3 | 0 | 2 |
| Tumor recurrence 5 years after treatment of cutaneous basal cell carcinoma and squamous cell carcinoma | 27.3 | 0 | 2 |
| Pattern of Nonmelanoma Skin Cancers in Sikkim, India: A 3-year Clinicopathological Review | 27.3 | 0 | 2 |
| Human polyomaviruses and incidence of cutaneous squamous cell carcinoma in the New Hampshire skin cancer study | 27.3 | 0 | 2 |
| Distribution of Basal Cell Carcinoma and Squamous Cell Carcinoma by Facial Esthetic Unit | 27.3 | 0 | 2 |
| Mohs Micrographic Surgery for skin cancer | 27.3 | 0 | 2 |
| Skin Cancer in the Crosshairs: Highlights from the Biennial Scientific Retreat of International Transplant Skin Cancer Collaborative and Skin Care in Organ Transplant Recipients Europe | 27.3 | 0 | 2 |
| Basal cell carcinoma of the skin with areas of squamous cell carcinoma: a basosquamous cell carcinoma? | 27.3 | 0 | 2 |
| Itch and Pain in Nonmelanoma Skin Cancer: Pain as an Important Feature of Cutaneous Squamous Cell Carcinoma | 27.3 | 0 | 2 |
| Perineural invasion of cutaneous squamous cell carcinoma and basal cell carcinoma: raising awareness and optimizing management | 27.3 | 0 | 2 |
| Expression of heparanase in basal cell carcinoma and squamous cell carcinoma | 27.3 | 0 | 2 |
| Basal cell carcinoma invading the umbilical stalk excised with Mohs micrographic surgery: case report and review of umbilical anatomy | 27.3 | 0 | 2 |
| Pigmented Basal Cell Carcinoma in Marjolin’s Ulcer | 27.3 | 0 | 2 |
| Treatment of cutaneous squamous cell carcinoma with perineural invasion using Mohs micrographic surgery: report of two cases and review of the literature | 27.3 | 0 | 2 |
| Treatment options for squamous cell carcinoma of the dorsal hand including Mohs micrographic surgery | 27.3 | 0 | 2 |
| Cost-effectiveness of surgical excision versus Mohs micrographic surgery for nonmelanoma skin cancer: A retrospective cohort study | 27.3 | 0 | 2 |
| Engaging patients in medication reconciliation via a patient portal following hospital discharge | 27.3 | 0 | 2 |
| Rapid wound re-epithelialization and basal cell carcinoma clearance after Mohs micrographic surgery with postoperative photodynamic therapy | 27.3 | 0 | 2 |
| Mohs Micrographic Surgery for Eyelid and Periorbital Skin Cancer | 27.3 | 0 | 2 |
| Squamous cell carcinoma arising in a nevus sebaceous of Jadassohn in a 9-year-old girl: treatment using Mohs micrographic surgery with literature review | 27.3 | 0 | 2 |
| Perineural infiltration of cutaneous squamous cell carcinoma and basal cell carcinoma without clinical features | 27.3 | 0 | 2 |
| Viral oncogenesis and its role in nonmelanoma skin cancer | 27.3 | 0 | 2 |
| An overview of Mohs micrographic surgery for the treatment of basal cell carcinoma | 27.3 | 0 | 2 |
| Mohs surgery for squamous cell carcinoma. | 27.3 | 0 | 2 |
| Peristomal skin care and the use of accessories to promote skin health | 27.3 | 0 | 2 |
| Skin cancer: a review with consideration of treatment options including Mohs micrographic surgery | 27.3 | 0 | 2 |
| Management of periocular basal cell carcinoma by Mohs micrographic surgery. | 27.3 | 0 | 2 |
| Malignant melanoma within squamous cell carcinoma and basal cell carcinoma: is it a combined or collision tumor?--a case report and review of the literature | 27.3 | 0 | 2 |
| Experience with molluscum contagiosum and associated inflammatory reactions in a pediatric dermatology practice: the bump that rashes | 27.3 | 0 | 2 |
| Characteristics of Basal Cell Carcinoma of the Lip Treated Using Mohs Micrographic Surgery | 27.3 | 0 | 2 |
| Characteristics of Squamous Cell Carcinoma In Situ of the Ear Treated Using Mohs Micrographic Surgery | 27.3 | 0 | 2 |
| Effect of GSTM1 polymorphism on risks of basal cell carcinoma and squamous cell carcinoma: a meta-analysis | 27.3 | 0 | 2 |
| Evaluating clinical dermatology practice in medical undergraduates | 27.3 | 0 | 2 |
| Confocal microscopy patterns in nonmelanoma skin cancer and clinical applications | 27.3 | 0 | 2 |
| Safety & efficacy of agents used for home mole removal and skin cancer treatment in the Internet age, and analysis of cases | 27.3 | 0 | 2 |
| Skin cancer and photoprotection in people of color: A review and recommendations for physicians and the public | 27.3 | 0 | 2 |
| Basosquamous carcinoma and metatypical basal cell carcinoma: a review of treatment with Mohs micrographic surgery | 27.3 | 0 | 2 |
| Opioid prescribing patterns after Mohs micrographic surgery and standard excision: a survey of American Society for Dermatologic Surgery members and a chart review at a single institution | 27.3 | 0 | 2 |
| Clinical spectrum of capillary malformation-arteriovenous malformation syndrome presenting to a pediatric dermatology practice: a retrospective study | 27.3 | 0 | 2 |
| Study to determine whether intraoperative frozen section biopsy improves surgical treatment of non-melanoma skin cancer | 27.3 | 0 | 2 |
| Randomized comparison of Mohs micrographic surgery and surgical excision for small nodular basal cell carcinoma: tissue-sparing outcome | 27.3 | 0 | 2 |
| On the horizon: Optical imaging for cutaneous squamous cell carcinoma | 27.3 | 0 | 2 |
| Frequency of squamous cell carcinoma (SCC) invasion in transected SCC in situ referred for Mohs surgery: the Dartmouth−Hitchcock experience | 27.3 | 0 | 2 |
| Association Between Mohs Surgery Wait Times and Surgical Defect Size in Patients With Squamous Cell or Basal Cell Carcinoma of the Skin | 27.3 | 0 | 2 |
| Immunohistologic differential diagnosis of basal cell carcinoma, squamous cell carcinoma, and trichoepithelioma in small cutaneous biopsy specimens | 27.3 | 0 | 2 |
| Laboratory Errors Leading to Nonmelanoma Skin Cancer Recurrence After Mohs Micrographic Surgery | 27.3 | 0 | 2 |
| Mohs Surgery for Squamous Cell Carcinoma of the Nail Unit: 10 Years of Experience | 27.3 | 0 | 2 |
| Characteristics and outcomes of nonmelanoma skin cancer (NMSC) in children and young adults | 27.3 | 0 | 2 |
| Squamous Cell Carcinoma in-situ and Basal Cell Carcinoma Arising From Seborrheic Keratosis in the Same Patient | 27.3 | 0 | 2 |
| Consensus for Nonmelanoma Skin Cancer Treatment, Part II: Squamous Cell Carcinoma, Including a Cost Analysis of Treatment Methods | 27.3 | 0 | 2 |
| Photodynamic Therapy for Basal Cell Carcinoma | 27.3 | 0 | 2 |
| Intralesional 5-fluorouracil (FU) as a treatment for nonmelanoma skin cancer (NMSC): A review | 27.3 | 0 | 2 |
| Patient interest in and familiarity with anti-aging therapies: A survey of the general dermatology clinic population | 27.3 | 0 | 2 |
| Reconstruction of Large Facial Defects after Delayed Mohs Surgery for Skin Cancer | 27.3 | 0 | 2 |
| A 10-year review of outpatient skin biopsy results and skin cancer subtypes | 27.3 | 0 | 2 |
| Mohs micrographic surgery for skin cancer | 27.3 | 0 | 2 |
| Diagnosis and Management of Hereditary Basal Cell Skin Cancer | 27.3 | 0 | 2 |
| Bensal HP for Second Intention Healing Following Mohs Micrographic Surgery or Shave Skin Biopsy: An Open-label Pilot Study | 27.3 | 0 | 2 |
| Outlier Practice Patterns in Mohs Micrographic Surgery: Defining the Problem and a Proposed Solution | 27.3 | 0 | 2 |
| Recurrence rates of periocular basal cell carcinoma following Mohs micrographic surgery: a retrospective study | 27.3 | 0 | 2 |
| The Use of Lipohydroxy Acid in Skin Care and Acne Treatment | 27.3 | 0 | 2 |
| Self-reported quality of life after skin cancer in young adults | 27.3 | 0 | 2 |
| Food intake and risk of squamous cell carcinoma of the skin in a community: the Nambour skin cancer cohort study | 27.3 | 0 | 2 |
| Shared medical appointments for the preoperative consultation visit of Mohs micrographic surgery | 27.3 | 0 | 2 |
| Basal cell carcinoma in a patient with acquired immunodeficiency syndrome: treatment with Mohs micrographic surgery fixed-tissue technique | 27.3 | 0 | 2 |
| Second-intention healing of exposed facial-scalp bone after Mohs surgery for skin cancer: review of ninety-one cases. | 27.3 | 0 | 2 |
| Cutaneous melanin density of Caucasians measured by spectrophotometry and risk of malignant melanoma, basal cell carcinoma, and squamous cell carcinoma of the skin | 27.3 | 0 | 2 |
| Anatomical Distributions of Basal Cell Carcinoma and Squamous Cell Carcinoma in a Population-Based Study in Queensland, Australia. | 27.3 | 0 | 2 |
| Actinic damage and skin cancer in albinos in northern Tanzania: findings in 164 patients enrolled in an outreach skin care program | 27.3 | 0 | 2 |
| Inexpensive digital photography in clinical dermatology and dermatologic surgery | 27.3 | 0 | 2 |
| Early investigation by fluor-18-fluorodeoxyglucose positron emission tomography of a metastatic basal cell carcinoma presenting with spinal cord compression: A case report | 27.3 | 0 | 2 |
| Quantification of PpIX concentration in basal cell carcinoma and squamous cell carcinoma models using spatial frequency domain imaging | 27.3 | 0 | 2 |
| Dermatologic surgery practice and skin cancer treatment in Canada: results of a national survey | 27.3 | 0 | 2 |
| Basal cell carcinoma and squamous cell carcinoma. Recognition and treatment | 27.3 | 0 | 2 |
| Cutaneous Lupus Erythematosus in Children: Experience from a Tertiary Care Pediatric Dermatology Clinic | 27.3 | 0 | 2 |
| Risks of different skin tumor combinations after a first melanoma, squamous cell carcinoma and basal cell carcinoma in Dutch population based cohorts: 1989 - 2009. | 27.3 | 0 | 2 |
| Mohs surgery for squamous cell carcinoma of the nail: report of 15 cases. Our experience and a long‐term follow‐up | 27.3 | 0 | 2 |
| A Statistical Analysis of a Pediatric Dermatology Clinic | 27.3 | 0 | 2 |
| Racial differences in skin cancer awareness and surveillance practices at a public hospital dermatology clinic | 27.3 | 0 | 2 |
| Incidence and Trends of Basal Cell Carcinoma and Cutaneous Squamous Cell Carcinoma: A Population-Based Study in Olmsted County, Minnesota, 2000 to 2010. | 27.3 | 0 | 2 |
| Skin cancer trends in Northern Ireland and consequences for provision of dermatology services. | 27.3 | 0 | 2 |
| A 13-Year Retrospective Study of Basal Cell Carcinoma in a Canadian Dermatology Practice: A Comparison Between Anatomical Location and Histopathologic Subtypes | 27.3 | 0 | 2 |
| Identifying and defining complications of dermatologic surgery to be tracked in the American College of Mohs Surgery (ACMS) Registry | 27.3 | 0 | 2 |
| Favourable results of Mohs micrographic surgery for basal cell carcinoma | 27.3 | 0 | 2 |
| Incidence ratio of basal cell carcinoma to squamous cell carcinoma equalizes with age. | 27.3 | 0 | 2 |
| Descriptive epidemiology of basal cell carcinoma and cutaneous squamous cell carcinoma in Soria (north-eastern Spain) 1998-2000: a hospital-based survey | 27.3 | 0 | 2 |
| Study on the Risk of Cutaneous Squamous Cell Carcinoma After Vismodegib Therapy for Basal Cell Carcinoma: Not a Case-Control Study | 27.3 | 0 | 2 |
| Differential BMI1, TWIST1, SNAI2 mRNA expression pattern correlation with malignancy type in a spectrum of common cutaneous malignancies: basal cell carcinoma, squamous cell carcinoma, and melanoma | 27.3 | 0 | 2 |
| P16INK4aImmunostaining but Lack of Human Papilloma Virus Type 16 in Cutaneous Squamous Cell Carcinoma and Basal Cell Carcinoma: a Report from West Iran | 27.3 | 0 | 2 |
| Analysis of skin diseases in a referral pediatric dermatology clinic in Thailand. | 27.3 | 0 | 2 |
| Squamous cell carcinoma developing within lichen planus of the penis. Treatment with Mohs micrographic surgery | 27.3 | 0 | 2 |
| Surgical treatment of basal cell carcinoma and squamous cell carcinoma | 27.3 | 0 | 2 |
| Treatment of basal cell carcinoma and squamous cell carcinoma with perineural invasion | 27.3 | 0 | 2 |
| Mohs surgery of basal cell carcinoma--a critical review | 27.3 | 0 | 2 |
| Access to Radiology Reports via an Online Patient Portal: Experiences of Referring Physicians and Patients | 27.3 | 0 | 2 |
| Increased Risk of Cutaneous Squamous Cell Carcinoma After Vismodegib Therapy for Basal Cell Carcinoma | 27.3 | 0 | 2 |
| Risk of skin cancer in multiple myeloma patients: a retrospective cohort study | 27.3 | 0 | 2 |
| Primary cutaneous myxoid spindle cell squamous cell carcinoma: a rare skin cancer | 27.3 | 0 | 2 |
| Costs and Economics of Skin Cancer Management, Mohs Surgery, and Surgical Reconstruction | 27.3 | 0 | 2 |
| Omental transplantation improves surgical outcome of large squamous cell carcinoma: A case report | 27.3 | 0 | 2 |
| Mohs micrographic surgery for nonmelanoma skin cancer | 27.3 | 0 | 2 |
| Squamous cell carcinoma. Case report of an unusually aggressive skin cancer | 27.3 | 0 | 2 |
| Clinical characteristics of malignant tumours originating in the external ear | 27.3 | 0 | 2 |
| Genetic association between TNF-α promoter polymorphism and susceptibility to squamous cell carcinoma, basal cell carcinoma, and melanoma: A meta-analysis | 27.3 | 0 | 2 |
| Comparison of electronic brachytherapy and Mohs micrographic surgery for the treatment of early-stage non-melanoma skin cancer: a matched pair cohort study | 27.3 | 0 | 2 |
| Delivering value in dermatology: Insights from skin cancer detection in routine clinical visits | 27.3 | 0 | 2 |
| Use of Ber-EP4 and Epithelial Specific Antigen to Differentiate Clinical Simulators of Basal Cell Carcinoma | 27.3 | 0 | 2 |
| Detection of Human Papillomavirus in Nonmelanoma Skin Cancer Lesions and Healthy Perilesional Skin in Kidney Transplant Recipients and Immunocompetent Patients | 27.3 | 0 | 2 |
| Penile squamous cell carcinoma: a review of the literature and case report treated with Mohs micrographic surgery | 27.3 | 0 | 2 |
| Selective in situ protein expression profiles correlate with distinct phenotypes of basal cell carcinoma and squamous cell carcinoma of the skin | 27.3 | 0 | 2 |
| Does the Dual Use of Toluidine Blue and Hematoxylin and Eosin Staining Improve Basal Cell Carcinoma Detection by Mohs Surgery Trainees? | 27.3 | 0 | 2 |
| Lamin expression in normal human skin, actinic keratosis, squamous cell carcinoma and basal cell carcinoma | 27.3 | 0 | 2 |
| Chemosurgical report: basal cell carcinoma involving the external auditory canal--treatment with Mohs micrographic surgery | 27.3 | 0 | 2 |
| Overexpression of phosphorylated-ATF2 and STAT3 in cutaneous squamous cell carcinoma, Bowen's disease and basal cell carcinoma | 27.3 | 0 | 2 |
| Clinicopathological analysis of basal cell carcinoma of the anal region and its distinction from basaloid squamous cell carcinoma | 27.3 | 0 | 2 |
| Excision vs Mohs surgery for basal cell carcinoma | 27.3 | 0 | 2 |
| Adjuvant cytokeratin staining in Mohs micrographic surgery for basal cell carcinoma. | 27.3 | 0 | 2 |
| Emergence of a squamous cell carcinoma phenotype following treatment of metastatic basal cell carcinoma with vismodegib | 27.3 | 0 | 2 |
| Skin cancer: Basal cell carcinoma--pay your money, take your choice | 27.3 | 0 | 2 |
| Modulation of basal and squamous cell carcinoma by endogenous estrogen in mouse models of skin cancer | 27.3 | 0 | 2 |
| Inserting ex vivo fluorescence confocal microscopy perioperatively in Mohs micrographic surgery expedites bedside assessment of excision margins in recurrent basal cell carcinoma | 27.3 | 0 | 2 |
| Immunohistochemical analysis of TIMP-3 and MMP-9 in actinic keratosis, squamous cell carcinoma of the skin, and basal cell carcinoma. | 27.3 | 0 | 2 |
| Mutations of the TERT promoter are common in basal cell carcinoma and squamous cell carcinoma | 27.3 | 0 | 2 |
| Periocular basal cell carcinoma: 5-year outcome following Slow Mohs surgery with formalin-fixed paraffin-embedded sections and delayed closure | 27.3 | 0 | 2 |
| Dermal changes in superficial basal cell carcinoma, melanoma in situ and actinic keratosis and their implications | 27.3 | 0 | 2 |
| The efficacy of curettage in delineating margins of basal cell carcinoma before Mohs micrographic surgery | 27.3 | 0 | 2 |
| BerEp4, cytokeratin 14, and cytokeratin 17 immunohistochemical staining aid in differentiation of basaloid squamous cell carcinoma from basal cell carcinoma with squamous metaplasia. | 27.3 | 0 | 2 |
| An overview of Bcl-2 expression in histopathological variants of basal cell carcinoma, squamous cell carcinoma, actinic keratosis and seborrheic keratosis. | 27.3 | 0 | 2 |
| The expression of c-erbB-1 and c-erbB-2 oncogenes in basal cell carcinoma and squamous cell carcinoma of skin | 27.3 | 0 | 2 |
| Re: Modulation of basal and squamous cell carcinoma by endogenous estrogen in mouse models of skin cancer | 27.3 | 0 | 2 |
| Histophotometric investigation of the nuclear DNA-content in normal epidermis, seborrheic keratosis, keratosis senilis, squamous cell carcinoma and basal cell carcinoma | 27.3 | 0 | 2 |
| SNodular basal cell carcinoma appearing as morpheaform during Mohs micrographic surgery. | 27.3 | 0 | 2 |
| Ultrastructural localization of gap junction protein connexin 43 in normal human skin, basal cell carcinoma, and squamous cell carcinoma | 27.3 | 0 | 2 |
| Nonmelanoma Skin Cancer: Disease-Specific Quality-of-Life Concerns and Distress | 27.3 | 0 | 2 |
| Atypical Adnexal Tumors Adjacent to Basal Cell Carcinoma: A Difficult Problem in Patients with Brooke-Spiegler Syndrome Undergoing Mohs Surgery | 27.3 | 0 | 2 |
| Basal cell carcinoma and squamous cell carcinoma growth rates and determinants of size in community patients | 27.3 | 0 | 2 |
| Standard surgical excision and reconstruction of giant basal cell carcinoma of the face: may be an alternative to the Mohs micrographic surgery | 27.3 | 0 | 2 |
| Efficacy of Fluorescence Diagnosis-guided Mohs Micrographic Surgery for Pigmented vs Non-pigmented Basal Cell Carcinoma | 27.3 | 0 | 2 |
| Basal Cell Carcinoma Overlying a Cardiac Pacemaker Successfully Treated Using Mohs Micrographic Surgery | 27.3 | 0 | 2 |
| Basal cell carcinoma of the ala nasi arising in a port wine stain treated using mohs micrographic surgery and local flap reconstruction | 27.3 | 0 | 2 |
| Multiple actinic keratosis, squamous cell carcinoma and basal cell carcinoma occurred after PUVA therapy in a Korean patient | 27.3 | 0 | 2 |
| Methyl aminolaevulinate-photodynamic therapy for actinic keratoses, squamous cell carcinoma in situ and superficial basal cell carcinoma employing a square wave intense pulsed light device for photoactivation | 27.3 | 0 | 2 |
| Innovative 19-minute rapid cytokeratin immunostaining of nonmelanoma skin cancer in Mohs micrographic surgery | 27.3 | 0 | 2 |
| Marjolin's ulcer: immunohistochemical study of 17 cases and comparison with common squamous cell carcinoma and basal cell carcinoma | 27.3 | 0 | 2 |
| The basal lamina in basal cell carcinoma, bowen’s disease, squamous cell carcinoma and keratoacanthoma: an immunoperoxidase study using an antibody to type IV Collagen | 27.3 | 0 | 2 |
| Measurements of the anatomical distribution of erythemal ultraviolet: a study comparing exposure distribution to the site incidence of solar keratoses, basal cell carcinoma and squamous cell carcinoma. | 27.3 | 0 | 2 |
| The density of epidermal p53 clones is higher adjacent to squamous cell carcinoma in comparison with basal cell carcinoma. | 27.3 | 0 | 2 |
| Squamous cell carcinoma: Could it be the most common skin cancer? | 27.3 | 0 | 2 |
| Multidisciplinary management of advanced basal cell carcinoma: report of four cases | 27.3 | 0 | 2 |
| A comparison of risk factors for malignant melanoma, squamous cell carcinoma and basal cell carcinoma in the UK. | 27.3 | 0 | 2 |
| Mohs surgery for basal cell carcinoma assisted by dermoscopy: report of two cases | 27.3 | 0 | 2 |
| Photodynamic therapy as adjuvant treatment of extensive basal cell carcinoma treated with Mohs micrographic surgery | 27.3 | 0 | 2 |
| The use of Mohs micrographic surgery for determination of residual tumor in incompletely excised basal cell carcinoma | 27.3 | 0 | 2 |
| Is curettage really necessary for basal cell carcinoma before Mohs micrographic surgery? | 27.3 | 0 | 2 |
| See-and-treat surgery for facial skin cancer | 27.3 | 0 | 2 |
| Population-based incidence of basal cell carcinoma in a Spanish Mediterranean area. | 27.3 | 0 | 2 |
| Altered distribution of 1-2B7B antigen in basal cell carcinoma, squamous cell carcinoma and Bowen's disease | 27.3 | 0 | 2 |
| Development of squamous cell carcinoma into basal cell carcinoma under treatment with Vismodegib | 27.3 | 0 | 2 |
| Protein expression of MMP-2 and MT1-MMP in actinic keratosis, squamous cell carcinoma of the skin, and basal cell carcinoma. | 27.3 | 0 | 2 |
| Treatment of aggressive basal cell carcinoma with intralesional interferon: Evaluation of efficacy by Mohs surgery | 27.3 | 0 | 2 |
| Nasal Valve Dysfunction after Mohs Surgery for Skin Cancer of the Nose | 27.3 | 0 | 2 |
| Basal Cell Carcinoma Treated with Mohs Surgery: A Comparison of 54 Younger Patients with 1050 Older Patients | 27.3 | 0 | 2 |
| Cowden's disease. Association with squamous cell carcinoma of the tongue and perianal basal cell carcinoma | 27.3 | 0 | 2 |
| Clinical triage of cutaneous squamous cell carcinoma and basal cell carcinoma to avoid treatment delay: value of an electronic booking system | 27.3 | 0 | 2 |
| Residual skin cancer after preoperative biopsy: evaluation by Mohs micrographic surgery | 27.3 | 0 | 2 |
| Risk of subsequent non-melanoma skin cancer in a cohort of patients with primary basal cell carcinoma | 27.3 | 0 | 2 |
| Commentary on the 'Reliability of skin biopsy in determining accurate tumor margins: a retrospective study following Mohs micrographic surgery'. | 27.3 | 0 | 2 |
| Mohs micrographic surgery for Basal cell carcinoma of the face | 27.3 | 0 | 2 |
| High recurrence rates of Basal cell carcinoma after mohs surgery in patients with chronic lymphocytic leukemia | 27.3 | 0 | 2 |
| Photodynamic treatment of basal cell carcinoma and squamous cell carcinoma with hypericin | 27.3 | 0 | 2 |
| Immunosuppressive level and other risk factors for basal cell carcinoma and squamous cell carcinoma in heart transplant recipients. | 27.3 | 0 | 2 |
| Randomized, controlled surgical trial of preoperative tumor curettage of basal cell carcinoma in Mohs micrographic surgery | 27.3 | 0 | 2 |
| Georgia's most common skin cancer: basal cell carcinoma | 27.3 | 0 | 2 |
| Mutation spectra of epidermal p53 clones adjacent to basal cell carcinoma and squamous cell carcinoma | 27.3 | 0 | 2 |
| Unique basaloid findings during Mohs surgery for basal cell carcinoma: a dermatopathology challenge | 27.3 | 0 | 2 |
| Incidence and risk factors for skin cancer following lung transplantation | 27.3 | 0 | 2 |
| Multiple subclinical syringomatous proliferations encountered during Mohs surgery for basal cell carcinoma | 27.3 | 0 | 2 |
| It's time for “keratinocyte carcinoma” to replace the term “nonmelanoma skin cancer” | 27.3 | 0 | 2 |
| Skin cancer evaluation in transplant patients: a physician opinion survey with recommendations | 27.3 | 0 | 2 |
| Squamous cell carcinoma of the maxillary sinus associated with nevoid basal cell carcinoma syndrome: report of a case with 21-year evaluation | 27.3 | 0 | 2 |
| Timing of subsequent new tumors in patients who present with basal cell carcinoma or cutaneous squamous cell carcinoma. | 27.3 | 0 | 2 |
| 5% imiquimod cream and reflectance-mode confocal microscopy as adjunct modalities to Mohs micrographic surgery for treatment of basal cell carcinoma | 27.3 | 0 | 2 |
| Chemical exposures other than arsenic are probably not important risk factors for squamous cell carcinoma, basal cell carcinoma and malignant melanoma of the skin | 27.3 | 0 | 2 |
| Vismodegib as a neoadjuvant treatment to Mohs surgery for aggressive basal cell carcinoma | 27.3 | 0 | 2 |
| Interferon therapy for basal cell carcinoma and squamous cell carcinoma | 27.3 | 0 | 2 |
| Family History of Skin Cancer Is Associated With Increased Risk of Cutaneous Squamous Cell Carcinoma | 27.3 | 0 | 2 |
| Standard excision and reconstruction as an alternative to MMS for giant basal cell carcinoma? | 27.3 | 0 | 2 |
| A massive neglected giant basal cell carcinoma in a schizophrenic patient treated successfully with vismodegib | 27.3 | 0 | 2 |
| An educational device for Mohs micrographic surgery. A three-dimensional model of basal cell carcinoma | 27.3 | 0 | 2 |
| Immunohistochemical assessment of endothelin-1 axis in psoriasis, basal cell carcinoma and squamous cell carcinoma | 27.3 | 0 | 2 |
| Non-melanoma Skin Cancer in Canada Chapter 4: Management of Basal Cell Carcinoma | 27.3 | 0 | 2 |
| Topical Brimonidine Gel as a Hemostatic Agent After Dermatologic Surgery | 27.3 | 0 | 2 |
| Mohs micrographic surgery for nonmelanoma skin cancer | 27.3 | 0 | 2 |
| BURNS and ERUPTS: novel mnemonics for detection of squamous cell carcinoma and basal cell carcinoma | 27.3 | 0 | 2 |
| Secondary Intention Healing following Mohs Micrographic Surgery for Basal Cell Carcinoma of the Nipple and Areola* | 27.3 | 0 | 2 |
| Basaloid squamous cell carcinoma with 'monster' cells: a mimic of pleomorphic basal cell carcinoma | 27.3 | 0 | 2 |
| Histological evaluation of residual basal cell carcinoma after shave biopsy prior to Mohs micrographic surgery | 27.3 | 0 | 2 |
| Commentary on Laboratory Errors Leading to Nonmelanoma Skin Cancer Recurrence Following Mohs Micrographic Surgery | 27.3 | 0 | 2 |
| Subsequent skin cancer in patients with early-onset basal cell carcinoma | 27.3 | 0 | 2 |
| Trends in basal cell carcinoma, squamous cell carcinoma, and melanoma of the skin from 1973 through 1987. | 27.3 | 0 | 2 |
| Use of Mohs micrographic surgery to establish quantitative proof of heightened tumor spread in basal cell carcinoma recurrent following radiotherapy | 27.3 | 0 | 2 |
| New primary basal cell carcinomas arising in skin flaps following Mohs micrographic surgery for primary and recurrent basal cell carcinoma | 27.3 | 0 | 2 |
| Mapping out skin cancer: Mohs micrographic surgery. | 27.3 | 0 | 2 |
| Squamous cell carcinoma and basal cell carcinoma within the clinical picture of a chronic venous insufficiency in the third stage | 27.3 | 0 | 2 |
| Basal cell carcinoma treated with Mohs surgery in Australia I. Experience over 10 years. | 27.3 | 0 | 2 |
| Basal cell carcinoma treated with Mohs surgery in Australia II. Outcome at 5-year follow-up. | 27.3 | 0 | 2 |
| Basal cell carcinoma treated with Mohs surgery in Australia III. Perineural invasion. | 27.3 | 0 | 2 |
| Re: Management of Nevus Sebaceous and the Risk of Basal Cell Carcinoma: An 18‐Year Review. By Rosen et al: Pediatric Dermatology v26, n6, 676–681, Nov/Dec 2009 | 27.3 | 0 | 2 |
| Multiple skin cancers in a single patient: Multiple pigmented Bowen's disease, giant basal cell carcinoma, squamous cell carcinoma | 27.3 | 0 | 2 |
| Peritumoral fibrosis in basal cell and squamous cell carcinoma mimicking perineural invasion: potential pitfall in Mohs micrographic surgery | 27.3 | 0 | 2 |
| Restylane persistent for 23 months found during Mohs micrographic surgery: a source of confusion with hyaluronic acid surrounding basal cell carcinoma | 27.3 | 0 | 2 |
| Diagnostic value of CD10 and Bcl2 expression in distinguishing cutaneous basal cell carcinoma from squamous cell carcinoma and seborrheic keratosis | 27.3 | 0 | 2 |
| Mohs micrographic surgery for basal cell carcinoma: evaluation of the indication criteria and predictive factors for extensive subclinical spread | 27.3 | 0 | 2 |
| Giant basal cell carcinoma of the face: surgical management and challenges for reconstruction | 27.3 | 0 | 2 |
| Polymorphisms of 5,10-methylenetetrahydrofolate reductase and thymidylate synthase in squamous cell carcinoma and basal cell carcinoma of the skin | 27.3 | 0 | 2 |
| Reliability of Self-Reported Information on Skin Cancer Among Elderly Patients with Squamous Cell Carcinoma | 27.3 | 0 | 2 |
| Limitations of Ber‐EP4 for distinction of Bowen disease from basal cell carcinoma | 27.3 | 0 | 2 |
| Can basal cell carcinoma lateral border be determined by fluorescence diagnosis?: Verification by Mohs micrographic surgery | 27.3 | 0 | 2 |
| 3D histology-guided surgery for basal cell carcinoma and squamous cell carcinoma: recurrence rates and clinical outcome | 27.3 | 0 | 2 |
| Penile basal cell carcinoma: two cases treated with Mohs micrographic surgery and remarks on pathogenesis | 27.3 | 0 | 2 |
| Sunlight exposure, pigmentary factors, and risk of nonmelanocytic skin cancer. I. Basal cell carcinoma | 27.3 | 0 | 2 |
| A Unique Basaloid Proliferation Encountered During Mohs Surgery: Potential Pitfall for Overdiagnosis of Basal Cell Carcinoma | 27.3 | 0 | 2 |
| Bispectral fluorescence imaging of aggressive basal cell carcinoma combined with histopathological mapping: a preliminary study indicating a possible adjunct to Mohs micrographic surgery | 27.3 | 0 | 2 |
| 5-year recurrence rates of Mohs micrographic surgery for aggressive and recurrent facial basal cell carcinoma | 27.3 | 0 | 2 |
| Basal cell carcinoma of the head region: therapeutical results of 350 lesions treated with Mohs micrographic surgery | 27.3 | 0 | 2 |
| Cost-effectiveness of Mohs Micrographic Surgery vs Surgical Excision for Basal Cell Carcinoma of the Face | 27.3 | 0 | 2 |
| Comparison of EMA,CEA, CD10 and Bcl-2 Biomarkers by Immunohistochemistry in Squamous Cell Carcinoma and Basal Cell Carcinoma of the Skin | 27.3 | 0 | 2 |
| Direct Cost-Analysis of Mohs Micrographic Surgery and Traditional Excision for Basal Cell Carcinoma at Initial Margin Clearance. | 27.3 | 0 | 2 |
| Basal cell carcinoma screening drives a comprehensive approach to skin cancer | 27.3 | 0 | 2 |
| Local immune modulator (imiquimod 5% cream) as adjuvant treatment after incomplete Mohs micrographic surgery for large, mixed type basal cell carcinoma: a report of 3 cases. | 27.3 | 0 | 2 |
| Mohs surgery for basal cell carcinoma | 27.3 | 0 | 2 |
| A Limited Immunohistochemical Panel to Distinguish Basal Cell Carcinoma of Cutaneous Origin From Basaloid Squamous Cell Carcinoma of the Head and Neck | 27.3 | 0 | 2 |
| Effects of ultraviolet radiation exposure on FOXP3+ infiltration in cutaneous squamous cell carcinoma and basal cell carcinoma | 27.3 | 0 | 2 |
| Economic impact of preoperative curettage before Mohs micrographic surgery for basal cell carcinoma | 27.3 | 0 | 2 |
| Follicular proliferation or basal cell carcinoma? The first prospective U.K. study of this histological challenge during Mohs surgery | 27.3 | 0 | 2 |
| Mohs micrographic surgery for periorbital skin cancer | 27.3 | 0 | 2 |
| Risk of synchronous and metachronous second nonmelanoma skin cancer when referred for Mohs micrographic surgery | 27.3 | 0 | 2 |
| Predicted cases of U.K. skin squamous cell carcinoma and basal cell carcinoma in 2020 and 2025: horizon planning for National Health Service dermatology and dermatopathology | 27.3 | 0 | 2 |
| The nevoid basal cell carcinoma syndrome--Gorlin's syndrome. Multiple jaw cysts and skin cancer | 27.3 | 0 | 2 |
| Study on the Risk of Cutaneous Squamous Cell Carcinoma After Vismodegib Therapy for Basal Cell Carcinoma: Not a Case-Control Study | 27.3 | 0 | 2 |
| Study on the Risk of Cutaneous Squamous Cell Carcinoma After Vismodegib Therapy for Basal Cell Carcinoma-Reply | 27.3 | 0 | 2 |
| Imiquimod 5% cream as pretreatment of Mohs micrographic surgery for nodular basal cell carcinoma in the face: a prospective randomized controlled study | 27.3 | 0 | 2 |
| Epidemiology of basal cell carcinoma and squamous cell carcinoma of the pinna | 27.3 | 0 | 2 |
| Difference between pigmented and nonpigmented basal cell carcinoma treated with Mohs micrographic surgery | 27.3 | 0 | 2 |
| Basal cell carcinoma growth in patients waiting for Mohs surgery: a prospective study | 27.3 | 0 | 2 |
| Standard step sectioning of skin biopsy specimens diagnosed as superficial basal cell carcinoma frequently yields deeper and more aggressive subtypes | 27.3 | 0 | 2 |
| Mohs micrographic surgery and surgical excision for nonmelanoma skin cancer treatment in the Medicare population | 27.3 | 0 | 2 |
| Use of Mohs Micrographic Surgery for the Treatment of Nonmelanoma Skin Cancer | 27.3 | 0 | 2 |
| Mohs surgery is the treatment of choice for recurrent (previously treated) basal cell carcinoma | 27.3 | 0 | 2 |
| Expression of oncogenic miR-17-92 and tumor suppressive miR-143-145 clusters in basal cell carcinoma and cutaneous squamous cell carcinoma. | 27.3 | 0 | 2 |
| The expression of p53 and cox-2 in basal cell carcinoma, squamous cell carcinoma and actinic keratosis cases | 27.3 | 0 | 2 |
| Skin cancer and surgical margins for basal cell carcinoma | 27.3 | 0 | 2 |
| The Method of En Face Frozen Section in Clearing Periocular Basal Cell Carcinoma and Squamous Cell Carcinoma | 27.3 | 0 | 2 |
| Dense inflammation does not mask residual primary basal cell carcinoma during Mohs micrographic surgery | 27.3 | 0 | 2 |
| Quality-of-life outcomes of treatments for cutaneous basal cell carcinoma and squamous cell carcinoma | 27.3 | 0 | 2 |
| Telomerase activity in Kaposi's sarcoma, squamous cell carcinoma, and basal cell carcinoma. | 27.3 | 0 | 2 |
| Polymorphisms in the DNA repair gene XRCC1 associated with basal cell carcinoma and squamous cell carcinoma of the skin in a Korean population | 27.3 | 0 | 2 |
| Sarcoidosis Discovered During Mohs Surgery for Basal Cell Carcinoma | 27.3 | 0 | 2 |
| Cost Analysis of Mohs Micrographic Surgery in High-Risk Facial Basal Cell Carcinoma | 27.3 | 0 | 2 |
| Risk of cutaneous squamous cell carcinoma after treatment of basal cell carcinoma with vismodegib. | 27.3 | 0 | 2 |
| Recurrent basal cell carcinoma and Mohs surgery. | 27.3 | 0 | 2 |
| Use of Mohs micrographic surgery to treat basal cell carcinoma arising in a nevus sebaceous in an African American patient | 27.3 | 0 | 2 |
| Hormonal and reproductive factors and incidence of basal cell carcinoma and squamous cell carcinoma in a large, prospective cohort. | 27.3 | 0 | 2 |
| Use of a Perimeter Technique with Mohs Micrographic Surgery in the Resection of a Giant Basal Cell Carcinoma | 27.3 | 0 | 2 |
| Macrophage subtypes in recurrent nodular basal cell carcinoma after Mohs micrographic surgery | 27.3 | 0 | 2 |
| Increased concentrations of 3,4-didehydroretinol and retinoic acid-binding protein (CRABPII) in human squamous cell carcinoma and keratoacanthoma but not in basal cell carcinoma of the skin | 27.3 | 0 | 2 |
| Correlation Between Incisional Biopsy Histological Subtype and a Mohs Surgery Specimen for Nonmelanoma Skin Cancer | 27.3 | 0 | 2 |
| Cutaneous Basal Cell Carcinoma with Dual Differentiation into Squamous Cell Carcinoma and Spindle Cell Squamous Cell Carcinoma: A Case Report with Immunohistochemical Studies | 27.3 | 0 | 2 |
| The Ratio of Basal Cell Carcinoma to Squamous Cell Carcinoma in Houston, Texas | 27.3 | 0 | 2 |
| Human cadaveric allograft for repair of nasal defects after extirpation of Basal cell carcinoma by Mohs micrographic surgery | 27.3 | 0 | 2 |
| Vitamin D Level and Basal Cell Carcinoma, Squamous Cell Carcinoma, and Melanoma Risk | 27.3 | 0 | 2 |
| Solitary sebaceous nevus of Jadassohn complicated by squamous cell carcinoma and basal cell carcinoma | 27.3 | 0 | 2 |
| Predictors of skin-related quality of life after treatment of cutaneous basal cell carcinoma and squamous cell carcinoma | 27.3 | 0 | 2 |
| CD-10 immunostaining differentiates superficial basal cell carcinoma from cutaneous squamous cell carcinoma | 27.3 | 0 | 2 |
| Longitudinal diminution of tumor size for basal cell carcinoma suggests shifting referral patterns for Mohs surgery | 27.3 | 0 | 2 |
| Incidence and risk factors associated with a second squamous cell carcinoma or basal cell carcinoma in psoralen + ultraviolet a light-treated psoriasis patients | 27.3 | 0 | 2 |
| A pilot study comparing toluidine blue and hematoxylin and eosin staining of basal cell and squamous cell carcinoma during Mohs surgery | 27.3 | 0 | 2 |
| Expression of CD40 and Fas ligand in Bowen's disease, squamous cell carcinoma and basal cell carcinoma | 27.3 | 0 | 2 |
| Methyl-ALA-induced fluorescence in photodynamic diagnosis of basal cell carcinoma prior to Mohs micrographic surgery. | 27.3 | 0 | 2 |
| Predictors of extensive subclinical spread in nonmelanoma skin cancer treated with Mohs micrographic surgery | 27.3 | 0 | 2 |
| Quantitative assessment of Langerhans cells in actinic keratosis, Bowen's disease, keratoacanthoma, squamous cell carcinoma and basal cell carcinoma | 27.3 | 0 | 2 |
| Excision of a peristomal basal cell carcinoma using Mohs micrographic surgery | 27.3 | 0 | 2 |
| Mohs surgery in the treatment of skin cancer. | 27.3 | 0 | 2 |
| Comparative analysis of immunohistochemical markers with invasiveness and histologic differentiation in squamous cell carcinoma and basal cell carcinoma of the skin | 27.3 | 0 | 2 |
| Expression of vascular endothelial growth factor in basal cell carcinoma and cutaneous squamous cell carcinoma of the head and neck | 27.3 | 0 | 2 |
| Validity of skin cancer malignancy reporting to the Organ Procurement Transplant Network: A cohort study | 27.3 | 0 | 2 |
| Skin cancer knowledge and preventive behaviors among patients with a recent history of cutaneous squamous cell carcinoma | 27.3 | 0 | 2 |
| Pediatric dermatology in practice: spectrum of skin diseases and approach to patients at a Turkish pediatric dermatology center | 27.3 | 0 | 2 |
| Dermatological Complications of Circumcision: Lesson Learned from Cases In a Pediatric Dermatology Practice | 27.3 | 0 | 2 |
| Obsessive-compulsive disorders in the pediatric dermatology practice | 27.3 | 0 | 2 |
| Office based dermatological surgery and Mohs surgery: A prospective audit of surgical procedures and complications in a procedural dermatology practice | 27.3 | 0 | 2 |
| Squamous cell carcinoma of the eyelids. Review of 7 years of experience of the adult ophthalmology service of the Casablanca university medical center | 27.3 | 0 | 2 |
| Mortality after dermatologic surgery for nonmelanoma skin cancer in patients aged 80 years and older | 27.3 | 0 | 2 |
| Detection of human papillomavirus in cutaneous clear cell squamous cell carcinoma in situ: viral-associated oncogenesis may contribute to the development of this pathologic variant of skin cancer | 27.3 | 0 | 2 |
| Expression of promyelocytic leukaemia protein in Bowen's disease, skin squamous cell carcinoma and basal cell carcinoma | 27.3 | 0 | 2 |
| Risk factors for basal cell carcinoma: a study from the national dermatology center of Colombia | 27.3 | 0 | 2 |
| The frequency of body dysmorphic disorder in dermatology and cosmetic dermatology clinics: a study from Turkey | 27.3 | 0 | 2 |
| The blind patient and the cosmetic dermatology consultation: Who defines beauty? | 27.3 | 0 | 2 |
| Skin cancer: risk to individuals using the tumour promoter benzoyl peroxide for acne treatment | 27.3 | 0 | 2 |
| Efficacy of Photodynamic Diagnosis-Guided Mohs Micrographic Surgery in Primary Squamous Cell Carcinoma | 27.3 | 0 | 2 |
| UV-Induced Molecular Signaling Differences in Melanoma and Non-melanoma Skin Cancer | 27.3 | 0 | 2 |
| Hair loss perception and symptoms of depression in female outpatients attending a general dermatology clinic | 27.3 | 0 | 2 |
| Medical Student Decision-Making: Standard Surgical Excision or Mohs Micrographic Surgery to Manage Basal Cell Carcinoma | 27.3 | 0 | 2 |
| Randomized controlled pilot study of the preoperative use of brimonidine 0.33% topical gel for hemostasis in Mohs micrographic surgery | 27.3 | 0 | 2 |
| Cosmeceuticals for Male Skin | 27.3 | 0 | 2 |
| Factors Influencing Squamous Cell Carcinoma In Situ Recurrence and Implications for Treatment Choice | 27.3 | 0 | 2 |
| How Mohs Surgery Transformed Into a First-Line Treatment of Skin Cancer | 27.3 | 0 | 2 |
| Clinical usefulness of Mohs' chemosurgery for palliative purposes in patients with cutaneous squamous cell carcinoma with risk factors or without indication for surgery: Three case reports | 27.3 | 0 | 2 |
| Use of a novel 1-hour protocol for rapid frozen section immunocytochemistry, in a case of squamous cell carcinoma treated with Mohs micrographic surgery | 27.3 | 0 | 2 |
| Retrospective audit of patients referred for further treatment following Mohs surgery for non-melanoma skin cancer. | 27.3 | 0 | 2 |
| Factors affecting choice of repair in Mohs micrographic surgery for non-melanoma skin cancer of the head. | 27.3 | 0 | 2 |
| What's up dermatology? A pilot survey of the use of WhatsApp in dermatology practice and case discussion among members of WhatsApp dermatology groups. | 27.3 | 0 | 2 |
| Recommendations for Solid Organ Transplantation for Transplant Candidates With a Pretransplant Diagnosis of Cutaneous Squamous Cell Carcinoma, Merkel Cell Carcinoma and Melanoma: A Consensus Opinion From the International Transplant Skin Cancer Coll | 27.3 | 0 | 2 |
| Features Causing Confusion between Basal Cell Carcinoma and Squamous Cell Carcinoma in Clinical Diagnosis | 27.3 | 0 | 2 |
| Non-melanoma skin cancer : Pathogenesis, prevalence and prevention | 27.3 | 0 | 2 |
| Re: "How Mohs Surgery Transformed Into a First-Line Treatment of Skin Cancer". | 27.3 | 0 | 2 |
| Complete treatment of basal cell carcinoma; cost effectiveness of Mohs micrographic surgery versus conventional excision | 27.3 | 0 | 2 |
| The perineural corona sign: Enhancing detection of perineural squamous cell carcinoma during Mohs micrographic surgery with toluidine blue stain | 27.3 | 0 | 2 |
| Family history of skin cancer is associated with early-onset basal cell carcinoma independent of MC1R genotype. | 27.3 | 0 | 2 |
| False-negative findings in skin cancer and melanoma screening. | 27.3 | 0 | 2 |
| Lack of selective attendance of participants at skin cancer/melanoma screening clinics | 27.3 | 0 | 2 |
| General practitioners' workload after skin cancer/melanoma screening clinics in The Netherlands | 27.3 | 0 | 2 |
| Melanonychia following mohs surgery for recurrent squamous cell carcinoma in situ of the nail bed. | 27.3 | 0 | 2 |
| Telomere length and risk of melanoma, squamous cell carcinoma, and basal cell carcinoma | 27.3 | 0 | 2 |
| Physician Survey Regarding Patient Nonattendance at Follow-up Appointments at a University-Affiliated Medical Dermatology Clinic | 27.3 | 0 | 2 |
| The Accuracy of Measurements of Nonmelanoma Skin Cancer Sizes Referred to the Mohs Surgery Clinic | 27.3 | 0 | 2 |
| W-modification of Abbe flap after Mohs surgery of squamous cell carcinoma on the lower lip. | 27.3 | 0 | 2 |
| Genital melanocytic nevi in children: Experience in a pediatric dermatology practice | 27.3 | 0 | 2 |
| Mohs surgery is effective for high-risk cutaneous squamous cell carcinoma | 27.3 | 0 | 2 |
| How good are skin cancer clinics at melanoma detection? Number needed to treat variability across a national clinic group in Australia | 27.3 | 0 | 2 |
| Shedding new light on the role of the sunshine vitamin D for skin health: the lncRNA‐skin cancer connection | 27.3 | 0 | 2 |
| Aggressive Squamous Cell Carcinoma Within A Burn Scar Complicated by M. Fortuitum Infection: Combination Treatment With Antibiotic Therapy, Mohs Surgery, Amnion-Chorion Graft, and Low-Intensity Pulsed Dye Laser | 27.3 | 0 | 2 |
| Developmental and psychosocial considerations in pediatric dermatology practice | 27.3 | 0 | 2 |
| Basic skin cancer triage for teaching melanoma detection | 27.3 | 0 | 2 |
| Alterations of the Human Skin N- and O-Glycome in Basal Cell Carcinoma and Squamous Cell Carcinoma | 27.3 | 0 | 2 |
| Therapeutic potential of the anti‐diabetic agent metformin in targeting the skin cancer stem cell diaspora | 27.3 | 0 | 2 |
| Non-melanoma Skin Cancer in Canada Chapter 5: Management of Squamous Cell Carcinoma | 27.3 | 0 | 2 |
| Methyl-aminolevulinic acid photodynamic therapy for actinic keratoses: a useful treatment or a risk factor? A retrospective study | 27.3 | 0 | 2 |
| Interdigital squamous cell carcinomain situsuccessfully treated with modified Mohs micrographic surgery and a split-thickness skin graft | 27.3 | 0 | 2 |
| Mohs micrographic surgery for squamous cell carcinoma associated with epidermolysis bullosa | 27.3 | 0 | 2 |
| [Mohs surgery for basal cell carcinoma]. | 27.3 | 0 | 2 |
| Lip Repair after Mohs Surgery for Squamous Cell Carcinoma by Bilateral Tissue Expanding Vermillion Myocutaneous Flap (Goldstein Technique Modified by Sawada). | 27.3 | 0 | 2 |
| Squamous Cell Carcinoma and Basal Cell Carcinoma--The Frontline for Pathophysiology. Diagnosis and Therapy | 27.3 | 0 | 2 |
| Comparison of P53 Intensity, Frequency and Size in Normal Skin Periphery of Squamous Cell Carcinoma, Basal Cell Carcinoma And Melanocytic Nevus in Persian Skin Type | 27.3 | 0 | 2 |
| Who attends skin cancer clinics within a randomized melanoma screening program? | 27.3 | 0 | 2 |
| A Predictive Model for Primary Closure Lengths in Mohs Surgery Based on Skin Cancer Type, Dimensions, and Location | 27.3 | 0 | 2 |
| A multi-center prevalence study and randomized controlled parallel-group pragmatic trial to compare the effectiveness of standardized skin care regimens on skin health in nursing home residents: a study protocol | 27.3 | 0 | 2 |
| Case Report: Squamous Cell Carcinoma Referred for Mohs Surgery Found to be Cutaneous Leishmaniasis | 27.3 | 0 | 2 |
| Designing a Patient Portal for Patient-Centered Care: Cross-Sectional Survey | 27.3 | 0 | 2 |
| Enhanced expression of nidogen 1 around the nest of basal cell carcinoma compared with that around squamous cell carcinoma | 27.3 | 0 | 2 |
| Incidence of Basal Cell Carcinoma and Squamous Cell Carcinoma in Patients on Antiprogrammed Cell Death-1 Therapy for Metastatic Melanoma | 27.3 | 0 | 2 |
| Commentary on Patients' Body Image Improves After Mohs Micrographic Surgery for Nonmelanoma Head and Neck Skin Cancer | 27.3 | 0 | 2 |
| Squamous cell carcinoma tumor thrombus encountered during Mohs micrographic surgery | 27.3 | 0 | 2 |
| Keratinocyte carcinomas arising near arteriovenous fistulas: Case series and safety considerations for dermatologic surgery: A report of the International Transplant Skin Cancer Collaborative | 27.3 | 0 | 2 |
| Exfoliative cytology for diagnosing basal cell carcinoma and other skin cancers in adults | 27.3 | 0 | 2 |
| Checking Wether the m-ALA Cream Could Mark Correctly the Borders of BCC's Tumors | 27.3 | 0 | 2 |
| Forehead Scars Following Mohs Micrographic Surgery and Reconstruction for Skin Cancer | 27.3 | 0 | 2 |
| Experience of Non-Melanoma Skin Cancer (NMSC) Mohs Surgery Project | 27.3 | 0 | 2 |
| Ex vivo fluorescence confocal microscopy in conjunction with Mohs micrographic surgery for cutaneous squamous cell carcinoma | 27.3 | 0 | 2 |
| Mobile Teledermatology for Melanoma Detection. Assessment of Validity in the Framework of a Population-based Skin Cancer Awareness Campaign in Northern Italy | 27.3 | 0 | 2 |
| Diagnosing Melanoma, Squamous Cell Carcinoma and Basal Cell Carcinoma Using the Spectra-Scope | 27.3 | 0 | 2 |
| Vismodegib for Treatment of Basal Cell Carcinoma | 27.3 | 0 | 2 |
| Absorbable Suture Versus Tissue Glue to Repair Defects Following Mohs Surgery | 27.3 | 0 | 2 |
| Photodynamic Therapy Using Methyl-5-Aminolevulinate Hydrochloride Cream in Determining Pain Threshold in Patients With Skin Cancer | 27.3 | 0 | 2 |
| Lidocaine Jelly for Pain Control During Mohs Surgery | 27.3 | 0 | 2 |
| The Role of Skin Care Regimen in Skin Health | 27.3 | 0 | 2 |
| Pilot Study of PDL to Treat BCC and SCCIS | 27.3 | 0 | 2 |
| Comparison of Elective Lymph Node Treatment Versus Clinical Observation in the Absence of Palpable Lymph Nodes for High Risk Skin Squamous Cell Carcinoma (SCC) | 27.3 | 0 | 2 |
| A Trial of Skin Care Protocols for Facial Resurfacing | 27.3 | 0 | 2 |
| Skin cancer precursor immunotherapy for squamous cell carcinoma prevention | 27.3 | 0 | 2 |
| Topical Green Tea Ointment in Treatment of Superficial Skin Cancer | 27.3 | 0 | 2 |
| Skin Health and Effectiveness of Standardized Skin Care Regimens in Nursing Home Residents | 27.3 | 0 | 2 |
| Nanocytology Test to Evaluate Skin Cancer in High Risk Patients | 27.3 | 0 | 2 |
| Basal Cell Carcinoma Recurrence After Mohs Surgery | 27.3 | 0 | 2 |
| Photodynamic Therapy Using Aminolevulinic Acid in Treating Patients With Skin Cancer | 27.3 | 0 | 2 |
| Screening for psychosocial dysfunction in pediatric dermatology practice | 27.3 | 0 | 2 |
| Nodal staging of high-risk cutaneous squamous cell carcinoma | 27.3 | 0 | 2 |
| A Study in Participants With Psoriatic Arthritis Attending Dermatology Clinics | 27.3 | 0 | 2 |
| A Study of Vismodegib With Surgery in Participants With Previously Untreated Basal Cell Carcinoma | 27.3 | 0 | 2 |
| Dasatinib in Treating Patients With Unresectable or Metastatic Squamous Cell Skin Cancer or RAI Stage 0-I Chronic Lymphocytic Leukemia | 27.3 | 0 | 2 |
| Pembrolizumab With or Without Vismodegib in Treating Metastatic or Unresectable Basal Cell Skin Cancer | 27.3 | 0 | 2 |
| Gefitinib in Treating Patients Who Are Undergoing Surgery and/or Radiation Therapy for Locally Advanced or Recurrent Squamous Cell Skin Cancer | 27.3 | 0 | 2 |
| Imiquimod Cream in Treating Patients With Basal Cell Skin Cancer | 27.3 | 0 | 2 |
| Isotretinoin in Preventing Skin Cancer | 27.3 | 0 | 2 |
| Topical Imiquimod Compared With Surgery in Treating Patients With Basal Cell Skin Cancer | 27.3 | 0 | 2 |
| Photodynamic Therapy in Treating Patients With Basal Cell Skin Cancer | 27.3 | 0 | 2 |
| Skin Health Online for Melanoma: Better Risk Assessment | 27.3 | 0 | 2 |
| Electronic Brachytherapy (eBx)-Mohs Matched Pair - Cohort Study A Multi-Center Retrospective-Prospective Matched Pairs Cohort Study to Assess Long-term Clinical Outcomes of Non-melanoma Skin Cancer Patients Treated With eBx Compared to Non-melan | 27.3 | 0 | 2 |
| Pembrolizumab in Patients With Locally Advanced or Metastatic Skin Cancer | 27.3 | 0 | 2 |
| A Study Comparing the Quality of Life of Patients in the Treatment of Eczema by Pediatric Generalists and Specialists | 27.3 | 0 | 2 |
| Study Evaluating Cemiplimab Alone and Combined With RP1 in Treating Advanced Squamous Skin Cancer | 27.3 | 0 | 2 |
| Buddy Relationships in DermatoloGic Excisions for Skin Cancer | 27.3 | 0 | 2 |
| A Study of Real-World Experience of Psoriasis Patients Treated With Apremilast in Clinical Dermatology Practice | 27.3 | 0 | 2 |
| Reflectance Confocal Microscopy in Basal Cell Carcinoma | 27.3 | 0 | 2 |
| Methods to speed healing after skin biopsy or trichloroacetic acid chemical peel | 27.3 | 0 | 2 |
| Basal cell carcinoma among the cases of Dermatology Clinic I of the Silesian Medical Academy in Katowice | 27.3 | 0 | 2 |
| New primary nonmelanoma skin cancer in patients with a history of squamous cell carcinoma of the skin. Implications and recommendations for follow-up | 27.3 | 0 | 2 |
| Management of superficial squamous cell carcinoma of the lip with Mohs micrographic surgery | 27.3 | 0 | 2 |
| DNA repair synthesis in fibroblast strains from patients with actinic keratosis, squamous cell carcinoma, basal cell carcinoma, or malignant melanoma after treatment with ultraviolet light, N-acetoxy-2-acetyl-aminofluorene, methyl methanesulfonate, | 27.3 | 0 | 2 |
| Morphological studies on basal cell carcinoma and squamous cell carcinoma in vitro (author's transl) | 27.3 | 0 | 2 |
| Mohs surgery report: an approach to cutaneous surgical defects of forehead and eyebrow following Mohs micrographic surgery | 27.3 | 0 | 2 |
| Subungual squamous cell carcinoma treated by Mohs surgery in a patient with sarcoidosis | 27.3 | 0 | 2 |
| Distribution of fibronectin and laminin in basal cell carcinoma and squamous cell carcinoma | 27.3 | 0 | 2 |
| [The dermatophytic flora surveyed at the Dermatology Clinic of the Tottori University Hospital from 1981 to 1984--statistic analysis of the patients of various clinical types and a comparative study of the ratios of T. rubrum/T. mentagrophytes at de | 27.3 | 0 | 2 |
| Prevalence of respiratory symptoms in children with atopic dermatitis attending pediatric dermatology clinics | 27.3 | 0 | 2 |
| Rapid cytokeratin stains enhance the sensitivity of Mohs micrographic surgery for squamous cell carcinoma | 27.3 | 0 | 2 |
| Lack of selective attendance of participants at skin cancer/melanoma screening clinics | 27.3 | 0 | 2 |
| Squamous cell carcinoma, basal cell carcinoma | 27.3 | 0 | 2 |
| 20-methylcholanthrene induced mouse skin cancer. Part 4: Study on the similarity between mouse skin cancer and human non-cicatric squamous cell carcinoma (author's transl) | 27.3 | 0 | 2 |
| Routine urinalysis in a general dermatology clinic | 27.3 | 0 | 2 |
| Squamous cell carcinoma arising from chronic osteomyelitis treated by Mohs micrographic surgery | 27.3 | 0 | 2 |
| "Sunshine and skin health": a curriculum for skin cancer prevention education | 27.3 | 0 | 2 |
| Sunlight exposure, pigmentation factors, and risk of nonmelanocytic skin cancer. II. Squamous cell carcinoma | 27.3 | 0 | 2 |
| 5th Meeting of the Spanish Pediatric Dermatology Group. Salamanca, Spain, January 28-29, 1994. Abstracts | 27.3 | 0 | 2 |
| Squamous cell carcinoma and basal cell carcinoma | 27.3 | 0 | 2 |
| Mohs surgery for basal cell carcinoma on the face | 27.3 | 0 | 2 |
| Desmoplastic squamous cell carcinoma of skin and vermilion surface: a highly malignant subtype of skin cancer | 27.3 | 0 | 2 |
| Squamous cell carcinoma arising in osteomyelitis and chronic wounds. Treatment with Mohs micrographic surgery vs amputation | 27.3 | 0 | 2 |
| Early melanoma detection. Skin cancer screening must become an insurance covered procedure | 27.3 | 0 | 2 |
| Status of residual tumor in patients with squamous cell carcinoma referred for Mohs micrographic surgery | 27.3 | 0 | 2 |
| Internet use among parents of patients of a pediatric dermatology clinic | 27.3 | 0 | 2 |
| Study of Cemiplimab in Patients With Type of Skin Cancer Stage II to IV Cutaneous Squamous Cell Carcinoma | 27.3 | 0 | 2 |
| Mohs micrographic surgery for facial skin cancer | 27.3 | 0 | 2 |
| Combined sentinel lymphadenectomy and mohs micrographic surgery for high-risk cutaneous squamous cell carcinoma | 27.3 | 0 | 2 |
| A prospective survey of pediatric dermatology clinic patients in Kuwait: an analysis of 10,000 cases | 27.3 | 0 | 2 |
| Squamous cell carcinoma arising from a nonhealing wound and osteomyelitis treated with Mohs micrographic surgery: a case study | 27.3 | 0 | 2 |
| STEROID OINTMENTS IN GENERAL DERMATOLOGICAL PRACTICE. I. BENEFITS OF A COD LIVER OIL--HYDROCORTISONE OINTMENT IN A GENERAL DERMATOLOGY PRACTICE. II. EXPERIENCES WITH AN IMPROVED STEROID CREAM FOR GENERAL DERMATOLOGIC CONDITIONS | 27.3 | 0 | 2 |
| Observations on skin cancer in the Zwickau skin clinic | 27.3 | 0 | 2 |
| A case of tarsal conjunctival squamous cell carcinoma treated with Mohs micrographic surgery | 27.3 | 0 | 2 |
| The cost of Mohs micrographic surgery for basal cell carcinoma. The Ambroise Paré hospital's experience (Boulogne, France) | 27.3 | 0 | 2 |
| Complications of systemic retinoid therapy in organ transplant recipients with squamous cell carcinoma | 27.3 | 0 | 2 |
| Cosmetic dermatology and skin care | 27.3 | 0 | 2 |
| The impact of cosmetic dermatology on skin care and cosmetics | 27.3 | 0 | 2 |
| Cost-effectiveness of Mohs micrographic surgery vs surgical excision for basal cell carcinoma of the face | 27.3 | 0 | 2 |
| Cutaneous squamous cell carcinoma treated with Mohs micrographic surgery in Australia I. Experience over 10 years | 27.3 | 0 | 2 |
| Cutaneous squamous cell carcinoma treated with Mohs micrographic surgery in Australia II. Perineural invasion | 27.3 | 0 | 2 |
| Mohs micrographic surgery for squamous cell carcinoma arising within lichen sclerosus | 27.3 | 0 | 2 |
| The kinetics of skin cancer: progression of actinic keratosis to squamous cell carcinoma | 27.3 | 0 | 2 |
| Diagnosis and treatment for squamous cell carcinoma and basal cell carcinoma of skin | 27.3 | 0 | 2 |
| Basal cell carcinoma. A skin cancer with a high cure rate | 27.3 | 0 | 2 |
| Mohs Micrographic Surgery for the management of basal cell carcinoma: experience at the Nîmes Univeristy Hospital | 27.3 | 0 | 2 |
| Therapeutic options for epithelial skin tumors. Actinic keratoses, Bowen disease, squamous cell carcinoma, and basal cell carcinoma | 27.3 | 0 | 2 |
| Eighteen years of experience in Mohs micrographic surgery and conventional excision for nonmelanoma skin cancer treated by a single facial plastic surgeon and pathologist | 27.3 | 0 | 2 |
| Mohs micrographic surgery for the treatment of basal cell carcinoma | 27.3 | 0 | 2 |
| Mohs surgery in basal cell carcinoma on the face | 27.3 | 0 | 2 |
| Comparative efficacy and safety results of topical hemostatic powder and sterile compressed foam sponge in second intention healing following Mohs micrographic surgery | 27.3 | 0 | 2 |
| Primary Cutaneous Lymphoepithelioma-Like Carcinoma Treated Using Mohs Micrographic Surgery and Zinc Chloride Fixative | 27.3 | 0 | 2 |
| Fate of medical dermatology in the era of cosmetic dermatology and dermatosurgery | 27.3 | 0 | 2 |
| Cryosurgery as Adjuvant to Mohs Micrographic Surgery in the Management of Subungual Squamous Cell Carcinoma | 27.3 | 0 | 2 |
| Eccrine syringofibroadenoma-like change adjacent to a squamous cell carcinoma: potential histologic pitfall in Mohs micrographic surgery | 27.3 | 0 | 2 |
| Prognosis of pretransplant melanoma | 27.3 | 0 | 2 |
| Melanoma in solid organ transplant recipients | 27.3 | 0 | 2 |
| Dermatology practice panorama. Acne treatment of Europeans especially negligent | 27.3 | 0 | 2 |
| What can you tell me about Mohs surgery for skin cancer? | 27.3 | 0 | 2 |
| Facing skin cancer surgery. Mohs surgery may be your best option for nonmelanoma skin cancers | 27.3 | 0 | 2 |
| Lessons learned in pediatric dermatology practice | 27.3 | 0 | 2 |
| Information from your family doctor. Skin cancer: basal cell and squamous cell carcinoma | 27.3 | 0 | 2 |
| Conjunctival Squamous Cell Carcinoma following Psoriasis Treatment | 27.3 | 0 | 2 |
| Primary eccrine carcinoma treated with Mohs micrographic surgery and adjuvant radiotherapy | 27.3 | 0 | 2 |
| Eccrine Carcinoma: The Role of Mohs Micrographic Surgery and a Review of the Literature | 27.3 | 0 | 2 |
| Mohs micrographic surgery in the treatment of trichilemmal carcinoma: The Mayo Clinic experience | 27.3 | 0 | 2 |
| Why Is Mohs Micrographic Surgery Underused in the Treatment of Dermatofibrosarcoma Protuberans in Children? | 27.3 | 0 | 2 |
| Acral Myxoinflammatory Fibroblastic Sarcoma Successfully Treated Using Mohs Micrographic Surgery | 27.3 | 0 | 2 |
| Five-Year Outcomes of Wide Excision and Mohs Micrographic Surgery for Primary Lentigo Maligna in an Academic Practice Cohort | 27.3 | 0 | 2 |
| Skin cancer screening campaigns in a Bucharest Dermatology Clinic | 27.3 | 0 | 2 |
| Teaching Cosmetic Dermatology Without Sacrificing the Proper Emphasis on Medical Dermatology | 27.3 | 0 | 2 |
| Tumor recurrence after Mohs micrographic surgery | 27.3 | 0 | 2 |
| Characteristics of Sebaceous Carcinoma and Early Outcomes of Treatment Using Mohs Micrographic Surgery Versus Wide Local Excision: An Update of the Mayo Clinic Experience Over the Past 2 Decades | 27.3 | 0 | 2 |
| Retrospective Review of Risk Factors Predictive of Complications in Patients After Below the Knee Mohs Micrographic Surgery | 27.3 | 0 | 2 |
| Technique for histological control of surgical margins in lip cancer | 27.3 | 0 | 2 |
| Skin carotenoid levels are not associated with risk of nonmelanoma skin cancer: response to "Supplement use and the risk of cutaneous squamous cell carcinoma" | 27.3 | 0 | 2 |
| Head and neck squamous cell carcinoma of unknown primary: Outcomes of a pre-defined institutional treatment policy in a region with a high prevalence of skin cancer | 27.3 | 0 | 2 |
| Reevaluating Mohs Surgery Appropriate Use Criteria for Primary Superficial Basal Cell Carcinoma | 27.3 | 0 | 2 |
| Chronic cutaneous graft-versus-host disease in children: A report of 14 patients from a tertiary care pediatric dermatology clinic | 27.3 | 0 | 2 |
| Analysis of cancer-associated fibroblasts and the epithelial-mesenchymal transition in cutaneous basal cell carcinoma, squamous cell carcinoma, and malignant melanoma | 27.3 | 0 | 2 |
| Introduction: Hot topics in neonatal skin care from the 13th World Congress of Pediatric Dermatology (Chicago, IL - July 6-9, 2017) | 27.3 | 0 | 2 |
| Mohs micrographic surgery for basal cell carcinoma of the scrotum | 27.3 | 0 | 2 |
| Impact of Mohs Micrographic Surgery on Tumor Staging of Cutaneous Squamous Cell Carcinoma: A Comparison of the 7th and 8th Editions of the American Joint Committee on Cancer Guidelines | 27.3 | 0 | 2 |
| Detection of skin cancer odours using dogs: a step forward in melanoma detection training and research methodologies | 27.3 | 0 | 2 |
| Knowledge of melanoma and nonmelanoma skin cancer among general dermatology patients | 27.3 | 0 | 2 |
| Patients' Body Image Improves After Mohs Micrographic Surgery for Nonmelanoma Head and Neck Skin Cancer | 27.3 | 0 | 2 |
| A Retrospective Clinical View of Basal Cell Carcinoma and Squamous Cell Carcinoma in the Head and Neck Region: A Single Institution's Experience of 247 Cases over 19 Years | 27.3 | 0 | 2 |
| A PD-1 Checkpoint Inhibitor (Cemiplimab) for High-Risk Localized, Locally Recurrent, or Regionally Advanced Skin Cancer | 27.3 | 0 | 2 |
| The new 8th edition of TNM staging and its implications for skin cancer: a review by the British Association of Dermatologists and the Royal College of Pathologists, U.K. | 27.3 | 0 | 2 |
| Needs and preferences of patients regarding basal cell carcinoma and cutaneous squamous cell carcinoma care: a qualitative focus group study | 27.3 | 0 | 2 |
| Low recurrence rate of head and neck basal cell carcinoma treated with Mohs micrographic surgery: A retrospective study of 1021 cases | 27.3 | 0 | 2 |
| Effectiveness of dermoscopy in Mohs micrographic surgery (MMS) for nonmelanoma skin cancer (NMSC) | 27.3 | 0 | 2 |
| External auditory meatus and/or conchal bowl reconstruction with postauricular island flap in patients with Basal Cell Carcinoma or Squamous Cell Carcinoma | 27.3 | 0 | 2 |
| A possible pitfall of Mohs surgery in collision tumor diagnosis: A case of a squamous cell carcinoma of the scalp overlying a metastatic breast lesion of the skull | 27.3 | 0 | 2 |
| Commentary on Patient Preferences for the Treatment of Basal Cell Carcinoma and Squamous Cell Carcinoma: A Mapping Review of Discrete Choice Experiments | 27.3 | 0 | 2 |
| Magnetic Resonance Imaging Findings Differentiating Cutaneous Basal Cell Carcinoma from Squamous Cell Carcinoma in the Head and Neck Region | 27.3 | 0 | 2 |
| Usefulness of real-time elastography for diagnosing lymph node metastasis of skin cancer: does elastography potentially eliminate the need for sentinel lymph node biopsy in squamous cell carcinoma? | 27.3 | 0 | 2 |
| Granuloma faciale arising on a scar after Mohs surgery for basal cell carcinoma | 27.3 | 0 | 2 |
| Intraoral Basal Cell Carcinoma Discovered During Mohs Micrographic Surgery | 27.3 | 0 | 2 |
| Commentary on Mohs Surgery as the Standard of Care for Nail Unit Squamous Cell Carcinoma | 27.3 | 0 | 2 |
| Mohs Micrographic Surgery as the Standard of Care for Nail Unit Squamous Cell Carcinoma | 27.3 | 0 | 2 |
| Early detection of melanoma: a consensus report from the Australian Skin and Skin Cancer Research Centre Melanoma Screening Summit | 27.3 | 0 | 2 |
| AXIN2 and SNAIL expression predict the risk of recurrence in cutaneous squamous cell carcinoma after Mohs micrographic surgery | 27.3 | 0 | 2 |
| Change in Sun-Protective Behavior After Dermatologic Surgery for Skin Cancer in High-Risk Patients | 27.3 | 0 | 2 |
| An audit of pain scores with conventional and white light topical 5-methyl aminolaevulinic acid photodynamic therapy for superficial basal cell carcinoma and squamous cell carcinoma in situ | 27.3 | 0 | 2 |
| Digital ex-vivo confocal imaging for fast Mohs surgery in nonmelanoma skin cancers: An emerging technique in dermatologic surgery | 27.3 | 0 | 2 |
| Skin cancer in transplant recipients: Scientific retreat of the international immunosuppression and transplant skin cancer collaborative and skin care in organ transplant patients-Europe | 27.3 | 0 | 2 |
| Addition of patient context to Mohs surgery synoptic reporting. Comment on 'Synoptic reporting in Mohs micrographic surgery' | 27.3 | 0 | 2 |
| Basal cell carcinoma of the vulva: treatment with Mohs micrographic surgery | 27.3 | 0 | 2 |
| A randomized phase II study evaluating vismodegib as neoadjuvant treatment of basal cell carcinoma preceding Mohs micrographic surgery: results and lessons learned | 27.3 | 0 | 2 |
| Nonmelanoma skin cancer - from actinic keratosis to cutaneous squamous cell carcinoma | 27.3 | 0 | 2 |
| Melanoma Within Basal Cell Carcinoma Nests Discovered During Mohs Micrographic Surgery | 27.3 | 0 | 2 |
| Risk factors for recurrence in cutaneous squamous cell carcinoma after Mohs micrographic surgery: A retrospective review of 237 Asian patients | 27.3 | 0 | 2 |
| Secondary-intention healing following Mohs micrographic surgery for squamous cell carcinoma of a finger | 27.3 | 0 | 2 |
| Basal cell carcinoma treated with Mohs micrographic surgery in young Ibero-American patients | 27.3 | 0 | 2 |
| Tissue-sparing properties of Mohs micrographic surgery for infiltrative basal cell carcinoma | 27.3 | 0 | 2 |
| Extremity nevus count is an independent risk factor for basal cell carcinoma and melanoma, but not squamous cell carcinoma | 27.3 | 0 | 2 |
| Recurrence rates of cutaneous squamous cell carcinoma of the head and neck after Mohs micrographic surgery vs. standard excision: a retrospective cohort study | 27.3 | 0 | 2 |
| Outcomes of Mohs Micrographic Surgery at the American Society for Dermatologic Surgery International Traveling Mentorship Program International Mohs Fellowship Recognition Units: A Retrospective Survey of 5889 Cases From South Africa, Romania, and t | 27.3 | 0 | 2 |
| Commentary on "Wait times, health care touchpoints, and nonattendance in an academic pediatric dermatology clinic" | 27.3 | 0 | 2 |
| Triple Collision Tumor Comprising Merkel Cell Carcinoma with an Unusual Immunophenotype, Squamous Cell Carcinoma In-Situ, and Basal Cell Carcinoma | 27.3 | 0 | 2 |
| Horizontal histological sections in the preliminary evaluation of basal cell carcinoma submitted to Mohs micrographic surgery | 27.3 | 0 | 2 |
| Risk factors for local recurrence of basal cell carcinoma and cutaneous squamous cell carcinoma of the middle third of the face: a 15-year retrospective analysis based on a single centre | 27.3 | 0 | 2 |
| Clinical outcomes in high-risk squamous cell carcinoma patients treated with Mohs micrographic surgery alone | 27.3 | 0 | 2 |
| Comment on: "Mobile teledermatology for melanoma detection: Assessment of validity in the framework of a population-based skin cancer awareness campaign in northern Italy" | 27.3 | 0 | 2 |
| Reply to: "Comment on 'Mobile teledermatology for melanoma detection: Assessment of validity in the framework of a population-based skin cancer awareness campaign in northern Italy'" | 27.3 | 0 | 2 |
| Long-term clinical outcomes of patients with invasive cutaneous squamous cell carcinoma treated with Mohs micrographic surgery: A 5-year, multicenter, prospective cohort study | 27.3 | 0 | 2 |
| Folliculocentric basaloid proliferation coexisting with basal cell carcinoma in Mohs Surgery: A potential cause of confusion | 27.3 | 0 | 2 |
| [Erratum to: Malignant collision tumor of the skin : Melanoma, squamous cell carcinoma and basal cell carcinoma] | 27.3 | 0 | 2 |
| Beyond the physician's perspective: A review of patient-reported outcomes in dermatologic surgery and cosmetic dermatology | 27.3 | 0 | 2 |
| Patient-Centered Care in Dermatologic Surgery: Practical Strategies to Improve the Patient Experience and Visit Satisfaction | 27.3 | 0 | 2 |
| Web-Based Skin Cancer Prevention Training for Massage Therapists: Protocol for the Massage Therapists Skin Health Awareness, Referral, and Education Study | 27.3 | 0 | 2 |
| Surgical excision, Mohs micrographic surgery, external-beam radiotherapy, or brachytherapy for indolent skin cancer: An international meta-analysis of 58 studies with 21,000 patients | 27.3 | 0 | 2 |
| Mohs micrographic surgery for cutaneous squamous cell carcinoma | 27.3 | 0 | 2 |
| [Malignant collision tumor of the skin : Melanoma, squamous cell carcinoma and basal cell carcinoma] | 27.3 | 0 | 2 |
| Wait times, health care touchpoints, and nonattendance in an academic pediatric dermatology clinic | 27.3 | 0 | 2 |
| Commentary on Retention Rates Among Patients Undergoing Multimodal Facial Rejuvenation Treatment Versus a Single Monotherapy in Cosmetic Dermatology Practices | 27.3 | 0 | 2 |
| Retention Rates Among Patients Undergoing Multimodal Facial Rejuvenation Treatment Versus a Single Monotherapy in Cosmetic Dermatology Practices | 27.3 | 0 | 2 |
| Reflectance confocal microscopy confirms residual basal cell carcinoma on clinically negative biopsy sites before Mohs micrographic surgery: A prospective study | 27.3 | 0 | 2 |
| Histopathologic upgrading of nonmelanoma skin cancer at the time of Mohs micrographic surgery: A prospective review | 27.3 | 0 | 2 |
| Having a first-degree relative with melanoma increases lifetime risk of melanoma, squamous cell carcinoma, and basal cell carcinoma | 27.3 | 0 | 2 |
| Quantity and characteristics of flap or graft repairs for skin cancer on the nose or ears: a comparison between Mohs micrographic surgery and plastic surgery | 27.3 | 0 | 2 |
| Basal Cell Carcinoma, Squamous Cell Carcinoma, and Cutaneous Melanoma in Skin of Color Patients | 27.3 | 0 | 2 |
| Integrating the concept of field cancerization in the classification and risk assessment of cutaneous squamous cell carcinoma: proposal for a new classification and terminology of keratinocyte skin cancer | 27.3 | 0 | 2 |
| Associations Between IL-10 Polymorphisms and Susceptibility to Melanoma, Basal Cell Carcinoma, and Squamous Cell Carcinoma: A Meta-Analysis | 27.3 | 0 | 2 |
| Revised Mohs surgery care guidelines for squamous cell carcinoma in-situ are overdue | 27.3 | 0 | 2 |
| Association between Blood Group and Nonmelanoma Skin Cancers (Basal Cell Carcinoma and Squamous Cell Carcinoma) | 27.3 | 0 | 2 |
| Neoadjuvant Vismodegib and Mohs Micrographic Surgery for Locally Advanced Periocular Basal Cell Carcinoma | 27.3 | 0 | 2 |
| Squamous cell carcinoma arising in a site of chronic osteomyelitis. Treatment with Mohs micrographic surgery | 27.3 | 0 | 2 |
| An Analysis of Biopsies for Suspected Skin Cancer at a Tertiary Care Dermatology Clinic in the Western Cape Province of South Africa | 27.3 | 0 | 2 |
| Skin cancer screening and melanoma detection: a life saved | 27.3 | 0 | 2 |
| Cosmetic/Surgical Dermatology: Should it be an Integrated Part of Medical Dermatology? | 27.3 | 0 | 2 |
| IV. Revised clinical practice guidelines for management of melanoma, squamous cell carcinoma, basal cell carcinoma and extramammary Paget's disease | 27.3 | 0 | 2 |
| Demographic and Tumor Characteristics of Patients Younger Than 50 Years With Nonmelanoma Skin Cancer Referred for Mohs Micrographic Surgery | 27.3 | 0 | 2 |
| Penile squamous cell carcinoma with urethral extension treated with Mohs micrographic surgery | 27.3 | 0 | 2 |
| Mohs Surgery for the Treatment of Skin Cancer: A Review of Guidelines | 27.3 | 0 | 2 |
| Perianal basal cell carcinoma treated with Mohs micrographic surgery | 27.3 | 0 | 2 |
| Basal cell carcinoma, squamous cell carcinoma and premalignant skin lesions--how to treat? | 27.3 | 0 | 2 |
| Giant Basal Cell Carcinoma including focal Squamous Cell Carcinoma of the Buttock: A Rare Case | 27.3 | 0 | 2 |
| Imvamune Vaccine for the Treatment of Non-melanoma Skin Cancer | 27.3 | 0 | 2 |
| Unusual Calcification Mimicking Periosteal Tumor Invasion in a Squamous Cell Carcinoma Treated With Mohs Micrographic Surgery | 27.3 | 0 | 2 |
| Topical Fluorouracil Therapy for Residual Superficial Basal Cell Carcinoma Following Mohs Micrographic Surgery | 27.3 | 0 | 2 |
| Skin Biopsy and Skin Cancer Treatment Utilization in the Medicare Population, 1993-2016 | 27.3 | 0 | 2 |
| A Deep Learning Algorithm to Detect the Presence of Basal Cell Carcinoma on Mohs Micrographic Surgery Frozen Sections | 27.3 | 0 | 2 |
| Evaluation of the Use of Capecitabine for the Treatment and Prevention of Actinic Keratoses, Squamous Cell Carcinoma, and Basal Cell Carcinoma: A Systematic Review | 27.3 | 0 | 2 |
| Comparison of basal cell carcinoma subtypes observed in preoperative biopsy and Mohs micrographic surgery | 27.3 | 0 | 2 |
| Identifying squamous cell carcinoma and cytokeratin-derived amyloid with pan-cytokeratin AE1/AE3 during Mohs micrographic surgery | 27.3 | 0 | 2 |
| Premalignant lesions, basal cell carcinoma and melanoma in patients with cutaneous squamous cell carcinoma | 27.3 | 0 | 2 |
| Low CD4+ T-cell nadir as a preoperative risk factor for squamous cell carcinoma with larger surgical margins during Mohs micrographic surgery among patients infected with the human immunodeficiency virus | 27.3 | 0 | 2 |
| The Epidemiology of Malignant Melanoma, Squamous Cell Carcinoma, and Basal Cell Carcinoma in the United Kingdom from 2004-2014: A Population-Based Cohort Analysis using the Clinical Practice Research Datalink | 27.3 | 0 | 2 |
| The application of skin care product in acne treatment | 27.3 | 0 | 2 |
| CD4+/CD8+ T-Cell Ratio Predictive of Surgical Margins in the Treatment of Nonmelanoma Skin Cancer Treated With Mohs Surgery of Patients Infected With the Human Immunodeficiency Virus | 27.3 | 0 | 2 |
| Attitudes on Prophylactic Antibiotic Use in Dermatologic Surgery: A Survey Study of American College of Mohs Surgery Members | 27.3 | 0 | 2 |
| Cosmetic Dermatology-An Often-Overlooked Tool for Medical Dermatology | 27.3 | 0 | 2 |
| A DEEP LEARNING ALGORITHM WITH HIGH SENSITIVITY FOR THE DETECTION OF BASAL CELL CARCINOMA IN MOHS SURGERY FROZEN SECTIONS | 27.3 | 0 | 2 |
| Basal cell carcinoma and squamous cell carcinoma in a single tumor in the anterior auricular area | 27.3 | 0 | 2 |
| Clinical efficacy of Mohs surgery combined with topical photodynamic therapy for facial basal cell carcinoma | 27.3 | 0 | 2 |
| Beyond Mohs Surgery and Excisions: A Focused Review of Treatment Options for Subtypes of Basal Cell Carcinoma | 27.3 | 0 | 2 |
| Mohs Micrographic Surgery for Head and Neck Nonmelanoma Skin Cancer: An Approach for Ent Surgeons | 27.3 | 0 | 2 |
| Immune suppression and cutaneous squamous cell carcinoma tumour biology | 27.3 | 0 | 2 |
| Felis catus papillomavirus type 2 infection and skin cancer in domestic cats | 27.3 | 0 | 2 |
| Recurrent squamous cell carcinoma with intracranial invasion of the dura mater after Mohs surgery | 27.3 | 0 | 2 |
| Photographic Rhinometry Following Derm/Mohs Surgery for Skin Cancers | 27.3 | 0 | 2 |
| Perineural Invasion of Cutaneous Squamous Cell Carcinoma and Basal Cell Carcinoma | 27.3 | 0 | 2 |
| Diagnosis of perineural invasion during Mohs micrographic surgery guides clinical decision-making in the management of cutaneous squamous cell carcinoma | 27.3 | 0 | 2 |
| Early detection of skin cancer using AI: Deciphering dermatology images for melanoma detection | 27.3 | 0 | 2 |
| LB1107 Enhancing cosmesis while achieving stellar cure rates for early stage non-melanoma skin cancer in the outpatient dermatology clinic using a novel non-invasive modality | 27.3 | 0 | 2 |
| Surgical Continuity of Care: A Multidisciplinary Approach to Managing the Mohs Micrographic Surgery Positive Deep Margin at the Parotid in Cutaneous Squamous Cell Carcinoma | 27.3 | 0 | 2 |
| An immunohistochemical study of bcl-2 protein expression in keratoacanthoma, as compared to squamous cell carcinoma and basal cell carcinoma | 27.3 | 0 | 2 |
| 579 Comparison of different sun-safety education interventions in changing sun exposure and protection practices in a general dermatology clinic: A pilot study | 27.3 | 0 | 2 |
| Keratoacantoma Like Squamous Cell Carcinoma and Basal Cell Carcinoma, Collision Tumor in the Skin | 27.3 | 0 | 2 |
| Epidemio-Clinical Profile of Skin Conditions in Pediatric Dermatology Consultation of the University Hospital of Treichville | 27.3 | 0 | 2 |
| Merkel cell carcinoma in collision with squamous cell carcinoma and basal cell carcinoma in a patient on ruxolitinib treatment for myeloproliferative neoplasm | 27.3 | 0 | 2 |
| Epidemiology of Keratinocyte Skin Cancer with a Focus on Cutaneous Squamous Cell Carcinoma | 27.3 | 0 | 2 |
| Removal of Incidental Skin Cancer During Mohs Micrographic Surgery Indicated for a Different Primary Tumor | 27.3 | 0 | 2 |
| Postoperative permanent section evaluation of Mohs micrographic surgery debulk specimens does not result in upstaging of cutaneous squamous cell carcinoma compared to stage at the completion of surgery: A retrospective case series | 27.3 | 0 | 2 |
| Su1847 - Epidemiology and Risk Factors of Malignant Melanoma, Squamous Cell Carcinoma and Basal Cell Carcinoma of the Skin in Ulcerative Colitis in the United States Between 2012 and 2017: Results from the Explorys Database | 27.3 | 0 | 2 |
| Coexisting Basal Cell Carcinoma and Squamous Cell Carcinoma in Congenital Nevus Sebaceous | 27.3 | 0 | 2 |
| Su1837 - Epidemiology and Risk Factors of Malignant Melanoma, Squamous Cell Carcinoma and Basal Cell Carcinoma of the Skin in Crohn's Disease in the United States Between 2012 and 2017: A Population Based Study | 27.3 | 0 | 2 |
| 233 Nevus count is an independent risk factor for basal cell carcinoma and melanoma, but not squamous cell carcinoma | 27.3 | 0 | 2 |
| Treatment Outcomes of Mohs Surgery vs. Imiquimod in Basal Cell Carcinoma | 27.3 | 0 | 2 |
| Causal relationship between the gut microbiome and basal cell carcinoma, melanoma skin cancer, ease of skin tanning: evidence from three two-sample mendelian randomisation studies | 27.3 | 0 | 2 |
| Dr. Busso Cosmetic Dermatology | 27.3 | 0 | 2 |
| Q135335149 | 27.3 | 0 | 2 |
| Q137043408 | 27.3 | 0 | 2 |
| Siam Dermatology | 27.3 | 0 | 2 |
| Clínica Hexsel de Dermatologia | 27.3 | 0 | 2 |
| National Center for Biotechnology Information | 25.8 | 1 | 0 |
| arXiv | 25.8 | 1 | 0 |
| JAMA Internal Medicine | 25.8 | 1 | 0 |
| Q180686 | 25.8 | 1 | 0 |
| JAMA Neurology | 25.8 | 1 | 0 |
| ADVFN | 25.8 | 1 | 0 |
| Francis Collins | 25.8 | 1 | 0 |
| HomoloGene | 25.8 | 1 | 0 |
| MedlinePlus | 25.8 | 1 | 0 |
| JAMA Psychiatry | 25.8 | 1 | 0 |
| Johns Hopkins School of Medicine | 25.8 | 1 | 0 |
| Blood | 25.8 | 1 | 0 |
| GenBank | 25.8 | 1 | 0 |
| Journal of Virology | 25.8 | 1 | 0 |
| Pennsylvania Hospital | 25.8 | 1 | 0 |
| Entrez | 25.8 | 1 | 0 |
| Johns Hopkins Hospital | 25.8 | 1 | 0 |
| Mount Sinai Hospital | 25.8 | 1 | 0 |
| polymyalgia rheumatica | 25.8 | 1 | 0 |
| Nanoscale Research Letters | 25.8 | 1 | 0 |
| Lou Ruvo Center for Brain Health | 25.8 | 1 | 0 |
| eLife | 25.8 | 1 | 0 |
| PeerJ | 25.8 | 1 | 0 |
| Biophysical Journal | 25.8 | 1 | 0 |
| University of Pennsylvania Press | 25.8 | 1 | 0 |
| Journal of Cardiovascular Magnetic Resonance | 25.8 | 1 | 0 |
| Mayo Clinic Hospital — Rochester | 25.8 | 1 | 0 |
| Cancer Biology and Therapy | 25.8 | 1 | 0 |
| Cancer Imaging | 25.8 | 1 | 0 |
| Japan Automobile Manufacturers Association | 25.8 | 1 | 0 |
| Merck Manual of Diagnosis and Therapy | 25.8 | 1 | 0 |
| Bioscience Reports | 25.8 | 1 | 0 |
| ACS Chemical Neuroscience | 25.8 | 1 | 0 |
| Acta Histochemica et Cytochemica | 25.8 | 1 | 0 |
| American Society of Clinical Oncology | 25.8 | 1 | 0 |
| Aging | 25.8 | 1 | 0 |
| GeneReviews | 25.8 | 1 | 0 |
| Mitsubishi Chemical Holdings | 25.8 | 1 | 0 |
| Biomicrofluidics | 25.8 | 1 | 0 |
| Journal of Experimental Medicine | 25.8 | 1 | 0 |
| Molecular and Cellular Biology | 25.8 | 1 | 0 |
| National Hospital for Neurology and Neurosurgery | 25.8 | 1 | 0 |
| WebMD | 25.8 | 1 | 0 |
| Eugene Koonin | 25.8 | 1 | 0 |
| JAMA Dermatology | 25.8 | 1 | 0 |
| Medscape | 25.8 | 1 | 0 |
| ABA Museum of Law | 25.8 | 1 | 0 |
| Airedale General Hospital | 25.8 | 1 | 0 |
| Johns Hopkins All Children's Hospital | 25.8 | 1 | 0 |
| American Academy of Dermatology | 25.8 | 1 | 0 |
| American Academy of Family Physicians | 25.8 | 1 | 0 |
| American Academy of Physician Assistants | 25.8 | 1 | 0 |
| American Board of Dermatology | 25.8 | 1 | 0 |
| JAMA Ophthalmology | 25.8 | 1 | 0 |
| JAMA Otolaryngology–Head & Neck Surgery | 25.8 | 1 | 0 |
| JAMA Pediatrics | 25.8 | 1 | 0 |
| Arthur L. Jenkins | 25.8 | 1 | 0 |
| British Skin Foundation | 25.8 | 1 | 0 |
| Canadian Journal of Gastroenterology & Hepatology | 25.8 | 1 | 0 |
| Canadian Respiratory Journal | 25.8 | 1 | 0 |
| Cancer Information Service | 25.8 | 1 | 0 |
| Castle Hill Hospital | 25.8 | 1 | 0 |
| Center for Medicare and Medicaid Innovation | 25.8 | 1 | 0 |
| Centers for Medicare and Medicaid Services | 25.8 | 1 | 0 |
| Cerebral Cortex | 25.8 | 1 | 0 |
| Change4Life | 25.8 | 1 | 0 |
| Chapel Allerton Hospital | 25.8 | 1 | 0 |
| Cheltenham General Hospital | 25.8 | 1 | 0 |
| Cn3D | 25.8 | 1 | 0 |
| Consensus CDS Project | 25.8 | 1 | 0 |
| Conserved Domain Database | 25.8 | 1 | 0 |
| Corbett Hospital | 25.8 | 1 | 0 |
| Corinne Goldsmith Dickinson Center for Multiple Sclerosis | 25.8 | 1 | 0 |
| CytoJournal | 25.8 | 1 | 0 |
| Diabetes Care | 25.8 | 1 | 0 |
| Entertainment and Sports Lawyer | 25.8 | 1 | 0 |
| Eukaryotic Cell | 25.8 | 1 | 0 |
| European Journal of Medical Research | 25.8 | 1 | 0 |
| Evidence-based Complementary and Alternative Medicine | 25.8 | 1 | 0 |
| Genetic codes | 25.8 | 1 | 0 |
| George Eliot Hospital | 25.8 | 1 | 0 |
| Geriatric orthopaedic surgery & rehabilitation | 25.8 | 1 | 0 |
| Global Health Action | 25.8 | 1 | 0 |
| Grantham and Kesteven Hospital | 25.8 | 1 | 0 |
| HSS Journal | 25.8 | 1 | 0 |
| International League Against Epilepsy | 25.8 | 1 | 0 |
| Hospital of the University of Pennsylvania | 25.8 | 1 | 0 |
| Howard County General Hospital | 25.8 | 1 | 0 |
| Hull Royal Infirmary | 25.8 | 1 | 0 |
| IBIS | 25.8 | 1 | 0 |
| Indian Journal of Nephrology | 25.8 | 1 | 0 |
| Indian Journal of Psychological Medicine | 25.8 | 1 | 0 |
| Institute for Strategic Dialogue | 25.8 | 1 | 0 |
| International Journal of Clinical and Experimental Medicine | 25.8 | 1 | 0 |
| International Journal of Clinical and Experimental Pathology | 25.8 | 1 | 0 |
| Journal of Cutaneous and Aesthetic Surgery | 25.8 | 1 | 0 |
| Journal of Medical Ethics | 25.8 | 1 | 0 |
| Journal of the Experimental Analysis of Behavior | 25.8 | 1 | 0 |
| Journal of the International AIDS Society | 25.8 | 1 | 0 |
| Lowestoft Hospital | 25.8 | 1 | 0 |
| Mayo Clinic Hospital – Jacksonville | 25.8 | 1 | 0 |
| Mayo School of Health Sciences | 25.8 | 1 | 0 |
| McGill Journal of Medicine | 25.8 | 1 | 0 |
| Medical News Today | 25.8 | 1 | 0 |
| Merck Veterinary Manual | 25.8 | 1 | 0 |
| Middle East Cancer Consortium | 25.8 | 1 | 0 |
| Milbank Quarterly | 25.8 | 1 | 0 |
| Molecular Medicine | 25.8 | 1 | 0 |
| Moorgreen Hospital | 25.8 | 1 | 0 |
| NYU Langone Health | 25.8 | 1 | 0 |
| National Comprehensive Cancer Network | 25.8 | 1 | 0 |
| National Provider Identifier | 25.8 | 1 | 0 |
| National Psoriasis Foundation | 25.8 | 1 | 0 |
| Northwick Park Hospital | 25.8 | 1 | 0 |
| Mass General Brigham | 25.8 | 1 | 0 |
| Penn Presbyterian Medical Center | 25.8 | 1 | 0 |
| Perelman Center for Advanced Medicine | 25.8 | 1 | 0 |
| Psychological Reports | 25.8 | 1 | 0 |
| Queen's Medical Centre | 25.8 | 1 | 0 |
| RefSeq | 25.8 | 1 | 0 |
| Rutgers University–Camden | 25.8 | 1 | 0 |
| Rutgers University–New Brunswick | 25.8 | 1 | 0 |
| Scheie Eye Institute | 25.8 | 1 | 0 |
| Sexually Transmitted Infections | 25.8 | 1 | 0 |
| Sheffield Children's Hospital | 25.8 | 1 | 0 |
| Sibley Memorial Hospital | 25.8 | 1 | 0 |
| SkinCeuticals | 25.8 | 1 | 0 |
| Sofia Frangou | 25.8 | 1 | 0 |
| South Tyneside District Hospital | 25.8 | 1 | 0 |
| St. Luke's Hospital, Bradford | 25.8 | 1 | 0 |
| St Catherine's Hospital | 25.8 | 1 | 0 |
| Stanford Hospital and Clinics | 25.8 | 1 | 0 |
| Stanford University Medical Center | 25.8 | 1 | 0 |
| Tameside and Glossop Integrated Care NHS Foundation Trust | 25.8 | 1 | 0 |
| The International Lawyer | 25.8 | 1 | 0 |
| The Journal of Chiropractic Education | 25.8 | 1 | 0 |
| The Merck Manuals | 25.8 | 1 | 0 |
| The Mount | 25.8 | 1 | 0 |
| UCSF Medical Center | 25.8 | 1 | 0 |
| UniGene | 25.8 | 1 | 0 |
| Univec | 25.8 | 1 | 0 |
| University of Pennsylvania Health System | 25.8 | 1 | 0 |
| Victor Velculescu | 25.8 | 1 | 0 |
| carcinoma | 17.2 | 0 | 1 |
| Karl Herxheimer | 17.2 | 0 | 1 |
| melanoma | 17.2 | 0 | 1 |
| Clearasil | 17.2 | 0 | 1 |
| equine sarcoid | 17.2 | 0 | 1 |
| squamous cell carcinoma | 17.2 | 0 | 1 |
| toner | 17.2 | 0 | 1 |
| exfoliation | 17.2 | 0 | 1 |
| intense pulsed light | 17.2 | 0 | 1 |
| cleanser | 17.2 | 0 | 1 |
| Revlon | 17.2 | 0 | 1 |
| Q1477309 | 17.2 | 0 | 1 |
| nevoid basal cell carcinoma syndrome | 17.2 | 0 | 1 |
| nasopharynx carcinoma | 17.2 | 0 | 1 |
| Merkel cell carcinoma | 17.2 | 0 | 1 |
| fibroepithelioma of Pinkus | 17.2 | 0 | 1 |
| sari cancer | 17.2 | 0 | 1 |
| liquid bandage | 17.2 | 0 | 1 |
| Biotherm | 17.2 | 0 | 1 |
| kangaroo care | 17.2 | 0 | 1 |
| Artistry | 17.2 | 0 | 1 |
| Squamous cell carcinoma | 17.2 | 0 | 1 |
| Fitzpatrick scale | 17.2 | 0 | 1 |
| chemical peel | 17.2 | 0 | 1 |
| Category:Skin cancer | 17.2 | 0 | 1 |
| adenosquamous carcinoma | 17.2 | 0 | 1 |
| dermal fillers | 17.2 | 0 | 1 |
| NARS Cosmetics | 17.2 | 0 | 1 |
| Aesop | 17.2 | 0 | 1 |
| Aquaphor | 17.2 | 0 | 1 |
| Aveeno | 17.2 | 0 | 1 |
| Photorejuvenation | 17.2 | 0 | 1 |
| Bronner Bros. | 17.2 | 0 | 1 |
| squamous cell thyroid carcinoma | 17.2 | 0 | 1 |
| Clarisonic | 17.2 | 0 | 1 |
| Comedone extraction | 17.2 | 0 | 1 |
| Cortactin | 17.2 | 0 | 1 |
| anti-aging cream | 17.2 | 0 | 1 |
| Ella Baché | 17.2 | 0 | 1 |
| facial care | 17.2 | 0 | 1 |
| Freederm | 17.2 | 0 | 1 |
| Glassy cell carcinoma of the cervix | 17.2 | 0 | 1 |
| Gold Bond | 17.2 | 0 | 1 |
| squamous cell carcinoma of the lung | 17.2 | 0 | 1 |
| list of cutaneous conditions associated with increased risk of nonmelanoma skin cancer | 17.2 | 0 | 1 |
| Natural skin care | 17.2 | 0 | 1 |
| patient-centered care | 17.2 | 0 | 1 |
| patient portal | 17.2 | 0 | 1 |
| Category:Deaths from skin cancer | 17.2 | 0 | 1 |
| Preetika Rao | 17.2 | 0 | 1 |
| Saudi Society of Dermatology and Dermatologic Surgery | 17.2 | 0 | 1 |
| Category:Skin care | 17.2 | 0 | 1 |
| Skin Cancer: Recognition and Management | 17.2 | 0 | 1 |
| skin biopsy | 17.2 | 0 | 1 |
| skin cancer in cats and dogs | 17.2 | 0 | 1 |
| spindle cell carcinoma | 17.2 | 0 | 1 |
| spindle cell squamous cell carcinoma | 17.2 | 0 | 1 |
| tumor protein p63 | 17.2 | 0 | 1 |
| verrucous carcinoma | 17.2 | 0 | 1 |